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ABSTRACT 
 While enteroviruses, including poliovirus, are conventionally released 
upon cell lysis, recent studies show that phosphatidylserine-enriched infectious 
extracellular vesicles (IEVs) shed by infected cells can transport clusters of enteroviruses 
from cell to cell, resulting in increased infectivity. Combining structural and biochemical 
analyses, we focused on IEVs shed from poliovirus-infected cells, a classical prototype 
for studying enteroviruses. Transmission cryo-electron microscopy, cryo-electron 
tomography and computational reconstruction, present the first three-dimensional 
structures of well-preserved IEVs and purified exosomes. We observed that single-
membraned IEVs present a wide size range in diameter. Clusters of virions can be either 
densely packed within a protein-coated irregularly shaped IEV, or concentrated at one or 
both ends of an IEV, forming a polar structure. In addition to virions, IEVs often contain 
internal vesicles, “ramen-noodle”-like structures with strong density, and partially 
assembled virion-like structures. Viral replication complex components, including viral 
proteins polymerase 3D, 3CD, 3A, 3AB, 2BC, 2C and (+) and (-) stranded RNAs were 
detected in IEVs. Furthermore, (-) stranded RNA templates are protected by the IEVs, not 
		 vii 
packed in viral capsids. The transported viral replication components (viral proteins and 
RNAs) and virions within IEVs initiate a stronger and faster viral replication in recipient 
cells than free virions. Both cryo-electron tomographic and mass spectrometry data also 
showed that virions and “ramen-noodle”-like structures were also observed in purified 
CD9 positive exosomes from poliovirus-infected cells. Viral protein 3AB, detected on the 
membrane of IEVs, can invaginate membranous structures to engulf large proteins into a 
closed lumen. Our study demonstrates that IEVs can transport viral replication complex 
components to initiate a rapid onset of viral replication, as part of a novel viral 
transmission mechanism. Viral protein 3AB may contribute to forming IEVs throughout 
the infection. 
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1. Introduction 
1.1 Poliovirus as an Irreplaceable Prototype in Modern Virology  
There is a saying that the history of modern virology is the history of poliovirus 
research. The origin of poliomyelitis probably dates back to antiquity, between 1580 and 
1350 B.C (Koch and Koch 1995, p6), while the first clear clinical description is generally 
attributed to Underwood in 1789 (Underwood 1789), reporting observations of a 
paralysis that targeted primarily children’s lower extremities. However, it was not until 
the early 20th century that polio-infection became a worldwide epidemic. In 1916, the 
worst polio-pandemic swept the U.S., afflicting more than 27,000 persons in New York 
City alone (Koch and Koch 1995, p5; De Jesus 2007). Although the vast majority of 
infected patients had no or only minor gastrointestinal symptoms (less than 1% of the 
infected people developed the severe paralytic form), the pandemic compelled the U.S. to 
profusely support poliomyelitis research. A virus as the causative agent for poliomyelitis 
was first established by Landsteiner and Popper (1909) who observed a successful 
transmission to monkeys using a bacteria-free intracerebral inoculation from a 
poliomyelitis-stricken child, in 1909. In the early 20th century, virology primarily 
evolved as a clinical discipline. The alimentary tract was later identified as the actual 
route of infection (Kling, Levaditil, and Lepine 1929). 
The first progress towards determining molecular features of poliovirus came in 
1955 when the crystal structure of poliovirus was reported: a spherical particle with a size 
of 28 nm in diameter (Schaffer and Schwerdt 1955). The X-ray crystallographic studies 
and first electron microscopic analysis showed a poliovirus particle consists of 60 
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identical sub-units with icosahedral symmetry (Finch and Klug 1959; Horne and 
Nagington 1959). Meanwhile, the successful cultivation of poliovirus in tissue culture 
and the development of plaque assays for quantitating infectivity paved the way for 
studies on the molecular biology of poliovirus (Dulbecco 1952). Studies of other human 
viruses such as Coxsackievirus and echovirus led to the early establishment of the class 
of enteroviruses, which includes poliovirus (Hsiung and Melnick 1958). Work in the 
1950’s on poliovirus RNA (Colter et al. 1957), replication cycle (Darnell 1958, 1962), 
the formation and release of mature viruses (Darnell 1958), and poliovirus-receptor 
interactions (Darnell and Sawyer 1960), shed light on the molecular features of 
enterovirus infection. Important advances continued in the 1960’s, including 1) 
identification of double-stranded RNA (dsRNA), which is comprised of a replicative 
form RNA (RF, Montagnier and Sanders 1963) and an intermediate form of RNA in 
polio-infected cells (RI, Girard 1969); 2) description of the virus RNA-dependent RNA 
polymerase (Baltimore and Franklin 1963); and 3) discovery of a single-open-reading 
frame and one complete polyprotein which is further self-cleaved into intermediate and 
mature protein products (Jacobson and Baltimore 1968a, 1968b; Kitamura et al. 1981; 
Kräusslich and Wimmer 1988).  
Another landmark in poliovirus research was determination of the entire 
nucleotide sequence of the poliovirus genome (Villa-Komaroff et al. 1975) and complete 
translation of the viral mRNA in vitro (Kitamura, Adler, and Wimmer 1980). Poliovirus 
genome was the first identified viral RNA genome. More scientific advances in 
poliovirus laid the foundation for modern genetic manipulation in modern virology 
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research: 1) application of recombinant DNA technology to poliovirus, 2) successful 
cloning of its genome and definition of its genetic fragments (Racaniello and Baltimore 
1981a, 1981b), and 3) identification of the first temperature-sensitive mutant (Cooper 
1968). Individual viral proteins and peptides were able to be identified and produced 
either by chemical synthesis or by cloning and expression of representative combined 
cDNA sequences in bacteria. Cloning of viral DNA greatly facilitated selection of 
specific mutants of poliovirus protein.   
Poliovirus has been intensely studied during the past 50 years. Indeed, poliovirus 
research parallels the advancement in our understanding of fundamental knowledge of 
RNA virus infection and virus-host interactions (Koch and Koch 1995, p10). Ever since 
its discovery, poliovirus, a simple non-enveloped virus, has been an irreplaceable 
prototype to study RNA virus infection.  
1.2 The virion 
Taxonomically (Yin-Murphy and Almond 1996; Ryu 2016), poliovirus is 
classified as a member of subfamilial genus enterovirus, belonging to the family 
picornaviridae. The picornaviridae represents a large family of small single-stranded (+) 
sense RNA viruses. Within this family, four best-known genera are enteroviruses (e.g. 
poliovirus, rhinovirus, Coxsackievirus, and echovirus); aphthovirus (foot-and-mouth 
disease virus), cardiovirus (encephalomyocarditis virus and Theiler’s virus), and 
hepatovirus (hepatitis A virus, HAV).  
Mature poliovirus virion is a small, spherical particle composed of 60 copies of 
four viral capsid proteins VP1, VP2, VP3, and VP4. Purified poliovirus does not contain 
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detectable amounts of sugar or lipid, thus it is classified as a non-enveloped virus. The 
four capsid proteins assume 2-, 3-, and 5- fold symmetry axes, together assembling into 
an icosahedron with 28 nm diameter (Figure 1.1). VP1, VP2 and VP3 are building blocks 
of the outer shell of poliovirus, with major neutralization antigenic sites, while VP4 
resides inside (Chow et al. 1987). VP4 can “breathe” and protrude out of the surface at 
physiological temperature (Li et al. 1994). The subunits of viral capsids are tightly 
packed with a strong impermeability and resistance to dyes, detergent, low pH, a variety 
of ions (e.g. Cs+) and small molecules, DNA and RNA proteases (Crowther and Melnick 
1961; Mayor and Diwan 1961; Koch and Koch 1995, p25). This neat and tight 
icosahedral lattice offers an optimum structural stability, efficient viral assembly, as well 
as a strong protection of the viral RNA genome against the harsh environment outside 
(Pearce and Pearce 1980; Koch and Koch 1995a, p25).  
The capsid shell harbors a single-stranded (+) sense RNA genome of 7500 
nucleotides. The genome is covalently linked at its 5’-end through a phosphodiester bond 
to a small viral peptide VPg. The genome (Figure 1.2) is organized into three domains: 5’ 
non-translated region (NTR), one single open reading frame (the coding region), and 3’ 
NTR. The genome contains multiple cis replication elements (CRE) located in the 2C and 
3D coding sequences. The 2C CRE region serves in the initiation of RNA replication. 
The 5’ NTR consists of the cloverleaf (CL) and the Internal Ribosomal Entry Site (IRES) 
elements, which are important for initiating viral replication and directing translation 
through interacting with host cell ribosomes, respectively. The 3’ NTR plays an 
important role in viral replication through circularizing with the 5’ NTR. The single open 
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reading frame (ORF) codes a 247 kDa polyprotein comprised of three domains: one 
structural region P1 (1ABCD), and two non-structural regions P2 (2ABCD) and P3 
(3ABCD). The polyprotein is further autocleaved into stable intermediates and final 
products (Figure 1.2). Although all nonstructural proteins work together to ensure a 
robust viral infection, the stable intermediate precursors 2BC, 3AB, 3CD have attracted 
attention due to their distinct roles from their final products (Figure 1.2), an interesting 
point that will be discussed later.  	 	
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1.1 Composition of poliovirus virions. (A) The cartoon model (modified from www. 
viralzone.expasy.org) shows that mature virions consist of a (+) sense RNA viral 
genome capped by VPg (3B) and capsid protein shell made of four capsid proteins 
VP1, VP2, VP3, VP4 (VP0 is cleaved into VP2 and VP4 in a mature virion). The 
virion is an icosahedral particle with a 28 nm diameter. (B) A high magnification 
electron micrograph of cell fragments from a poliovirus infected cell at 4 hpi. The 5-
fold symmetric arrangement is pointed out by black arrows. The white density 
displays protein structures and arrangements (Horne	and	Nagington	1959). (C) A 16 
nm thick cryo-electron micrograph of a virion near a membrane. The dark electron 
density indicates protein and lipid structures. The scale bar is 28 nm. (D) An electron 
micrograph of viral particles stained with 1% PTA (Boublik	and	Drzeniek	1977). 
The scale bar is 0.1 µm.  
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1.3 The life cycle of poliovirus 
Poliovirus infection is characterized by a series of important subsequent events: 
virus entry and RNA genome release; viral protein translation and translation-to-
replication switch, replication-induced replication membranous structures, virion 
assembly, maturation, and release. Alterations to host cells accompany the virus 
replication process (Boublik and Drzeniek 1977). 
1.3.1 Receptor binding and cell entry 
There are two models of the pathway by which poliovirus enters cells. In the first 
model, poliovirus infection is initiated upon adhesion and binding of the virus to the 
poliovirus receptor, CD155, on the plasma membrane (Mendelsohn, Wimmer, and 
Racaniello 1989). An irreversible conformational change in viral capsids is induced upon 
capsid proteins-CD155 interaction, changing from its native, mature 160S particle into an 
altered infectious particle of 135S (De Sena and Mandel 1977). This transition is 
characterized by the loss of capsid protein VP4 and externalization of the N-terminus of 
the capsid protein VP1 from inside of a virion into the plasma membrane. These 
conformational changes allow the viral particle to anchor to the plasma membrane in a 
receptor-independent manner (Chow et al. 1987; Fricks and Hogle 1990). These 
conformational changes further lead to a channel or pore formation in the plasma 
membrane. Therefore, it is suggested that the viral genome is translocated into the 
cytoplasm across the plasma membrane, through a pore formed by membrane-associated 
viral capsid proteins (Hogle 2002). Genome release results in the formation of a stable 
empty particle, called the 80S particle (Belnap et al. 2000). In the second model, 
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poliovirus must enter the cell before releasing its viral genome (Brandenburg et al. 2007). 
In this model, poliovirus binds to receptors on the cell surface and is internalized. This 
process does not require clathrin-, caveolin-, flotillin-, or microtubule trafficking 
mechanisms. However it is conducted via a tyrosine kinase- and actin-dependent, 
endocytic pathway. Tracking viral entry at the single-virion level in live cells showed that 
at physiological temperature, 37 °C, viral RNA genome release from the capsids is ATP-
dependent, rapid and efficient. Viral RNA undergoes disruption of its secondary structure 
after virus internalization from vesicles near the plasma membrane (Brandenburg et al. 
2007). 
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Figure 1.2 Genomic structure of poliovirus and viral protein products (modified 
from Jiang et al. 2014). The poliovirus genome consists of a single stranded, positive 
(+) sense polarity RNA molecule. The (+) sense RNA is organized into a 5’ NTR 
(including cloverleaf and IRES elements), one single open reading frame, and a poly-
adenylated 3’ NTR. The single open reading frame is translated into one polypeptide 
that contains structural (P1) and non-structural (P2 & P3) regions. Structural and non-
structural regions are cleaved by multiple virally-encoded proteinases to generate 
stable intermediates and final viral proteins. Three stable intermediates (2BC, 3CD, 
and 3AB) exhibit functions distinct from those of their respective final cleaved 
products.  
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1.3.2 Poliovirus RNA Replication and Release 
Poliovirus is a single-stranded, positive-sense RNA virus. Viral genome 
replication is preceded by translation to generate essential replication proteins, because 
(+) sense viral RNA cannot use A host RNA-dependent RNA polymerase . The viral 
RNA is translated in a single open reading frame to produce a polyprotein, which is 
further cleaved into stable intermediates and final products (Jacobson and Baltimore 
1968b) (Figure 1.3).  
The buildup of viral proteins signals the shift from translation to transcription, 
which is regulated by viral protease 3CD (Andino et al. 1990). Protein 3CD mediates the 
shift through binding to the cis-replicating element (CRE) segment on the viral RNA 
genome, which provides a fast on-and-off mechanism to promote transcription and 
translation simultaneously (Herold and Andino 2001). By definition, the positive-sense 
RNA genome needs to generate a negative RNA template in order to replicate. The 
synthesis of complementary (-) sense RNA templates starts with the circularization of the 
(+) sense RNA mediated by viral protein 3CD, viral RNA-dependent RNA polymerase 
3D, PCBP (a host cellular protein bound to viral RNA to promote translation of the viral 
genome), and 5’- and 3’- nucleoprotein complexes (Andino et al. 1993). This action 
generates an unstable double-stranded RNA structure that is comprised of a (+) and a (-) 
sense RNA, called replicative form (RF) RNA. The unstable RF RNA quickly separates. 
The polymerase protein 3D then uses the separated (-) sense RNA as a template to create 
(+) sense RNA with high efficiency. The mixture of (+) and (-) sense RNA is called the 
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Replicative Intermediate (RI). Thus, the presence of double-stranded RNAs (RI and or 
RF) indicates the active replication site in infected cells.  
 
	
Figure 1.3 The life cycle of poliovirus infection. 
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Figure 1.3 The life cycle of poliovirus infection. Poliovirus infection is initiated 
upon binding of the virus to the CD155 receptor on the plasma membrane (1) and 
internalized (2). The genome is released from the endocytic vesicle and VPg is 
released from the (+) sense RNA viral genome. The uncapped (+) sense RNA genome 
is translated into a polyprotein that is further cleaved into structural and non-structural 
proteins (3). Viral proteins, RNAs, host proteins and membranous structures together 
form the viral replication complex (4). In the replication complex, viral RNA-
dependent RNA polymerase (3D) mediates the generation of the (-) sense RNA 
template, forming replicative form (RF) RNAs and replicative intermediate (RI) 
RNAs. Daughter (+) sense RNAs can be either used for translation or capped and 
packaged into immature progeny virions, followed by virion maturation (5). Progeny 
virions can then be released into extracellular space upon cell membrane dismantling 
(cell lysis) (6). Alternatively, multiple progeny virions can be transported through 
vesicle-mediated cell-to-cell transmission prior to cell lysis (6).  
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Meanwhile, viral replication induces and depends on, altered lipid metabolism 
and membrane remodeling, which is a classic morphological change observed in RNA 
virus-infected cells. In the early stage of poliovirus infection, phospholipid synthesis and 
trafficking is significantly up-regulated and hijacked (Vance et al. 1980; Guinea and 
Carrasco 1991). Newly synthesized viral proteins, genome RNAs, host proteins, 
remodeled membrane structures together generate a unique membranous scaffold 
wherein large amount of progeny RNA and assembled viral particles are produced (Koch 
and Koch 1995, p225). This membrane-associated complex which consists of 
constructive components and generated viral products, is the site for viral replication, and 
termed the viral replication machinery (Bienz et al. 1987). 
Cleaved capsid proteins VP1, VP3 and immature capsid protein myristoyl-VP0 
assemble into pentameric intermediates that subsequently form an empty capsid with 60 
copies of each protein (Ansardi et al. 1994; Ansardi et al. 1996). It has been unclear 
whether the encapsidation of viral RNA genome is mediated by pentamers or by insertion 
into pre-assembled empty capsids. However, impairing de novo synthesis of progeny 
RNAs inhibits encapsidation. Assembled RNA and 60 copies of VP0, VP1, VP3 proteins 
form provirions or immature virions. Immature virions undergo maturation wherein VP0 
is processed into VP4 and VP2. The maturation process is closely related to the 
autophagic acidification pathway (Richards and Jackson 2012). Conventionally, 
poliovirus, like all non-enveloped viruses, is released when dismantling the plasma 
membrane. However, it has been reported that, before cell lysis (the plasma membrane is 
intact), around 8 hpi, multiple virions can be packed into a double-membraned vesicle 
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inside infected cells and released into the extracellular space en bloc, within a single-
membraned, phosphatidylserine (PS)-rich vesicle (Colbère-Garapin et al. 1989; Lloyd 
and Bovee 1993; Jackson et al. 2005; Bird et al. 2014; Chen et al. 2015; Altan-Bonnet 
2016). This unconventional pathway is important because compared to free virions at the 
same MOI, virion-containing vesicles are able to induce a stronger accumulation of viral 
proteins in an infection cycle in recipient cells (Chen et al. 2015). The autophagic 
pathway is also involved in this novel viral release in infected cells, in that inhibition of 
autophagy leads to a decrease in the release of virion-containing vesicles into the 
extracellular space (Jackson et al. 2005; Taylor and Jackson 2009; Bird et al. 2014; 
Robinson et al. 2014; Chen et al. 2015). The non-lytic viral transmission pathway is very 
interesting because vesicle-mediated transportation, reminiscent of the transmission of 
enveloped viruses, is likely to alter interactions between virions and host immune 
surveillance. Evading host immune system is one of the biggest challenges that virions 
face to survive in the harsh environment (immune response, pH, anatomic barriers, 
temperature, etc). Nevertheless, little is known about this non-lytic viral transmission 
pathway.  
1.4 Virus-induced Membrane Remodeling 
As discussed above, virus-induced membranous structures are an essential 
component of the viral replication complexes or machinery. Additionally, these 
membranous structures are the most conspicuous morphological alteration in the host cell 
during infection (reviewed in Rossignol et al. 2015). Electron microscopy remains the 
most reliable way to study cellular ultrastructure. Visible morphological alterations start 
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as early as 2.5 hpi (Kallman et al. 1958; Bienz, Egger, and Pasamontes 1987), 
characterized by ER membrane blebbing. At 3 hpi to 4 hpi, single-membrane vesicular 
structures are observed around the ER and nucleus (Dales et al. 1965; Bienz, Egger, and 
Pasamontes 1987; Belov et al. 2012), which corresponds to the peak of viral replication 
(Scharff and Levintow 1963).  Consistent with previous studies, our laboratory’s data 
showed that some vesicles have interior density, similar to threads that appear RNA-like 
(unpublished data). Around 5 hpi, viral particles, some of which are empty capsids, are 
observed near or within these vesicles (Schlegel et al. 1996).  At 7 hpi, double membrane 
vesicles with an average size of 100 to 200 nm in diameter are predominant wherein 
virions are packed inside (Dales et al. 1965; Belov et al. 2012; Rossignol, Yang, and 
Bullitt 2015). Multiple interactions contribute to viral replication and maturation through 
membrane remodeling, such as interactions between proteins and lipids, virus-induced 
lipid metabolism, and the hijacked cellular vesicular trafficking pathway. In particular, 
membrane-associated viral proteins 2BC, 2C, 3AB, 3A have been identified in the 
replication complex, tightly associated with viral replication (Bienz, Egger, and 
Pasamontes 1987; Natalya L. Teterina et al. 2011; Jackson 2014; Altan-Bonnet 2017). 
1.5 Stable Intermediates and their Final Products 
1.5.1 2BC/2C 
Individual expression of membrane-associated poliovirus proteins has been 
utilized to understand the roles of viral proteins in membrane remodeling during infection. 
Viral protein 2C and its precursor 2BC, containing two amphipathic α-helix domains for 
membrane-binding (Aldabe et al. 1996; van Kuppeveld et al. 1996), leads to clusters of 
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large single-membrane vesicles with a size ranging from 50 to 350 nm in diameter that 
fill most of the cytoplasm when expressed in HeLa and yeast cells (Figure 1.4) (Cho et al. 
1994; Teterina et al. 1997). These vesicles are morphologically similar to the cytopathic 
vacuoles observed during poliovirus infection (Suhy et al. 2000). An additional 
prominent alteration in cells expressing 2C but not 2BC was the formation of extensive 
tubular membrane structures (Figure 1.4) (Teterina et al. 1997). Individual expression of 
2BC with an intact membrane-binding activity suffices to increase the cytoplasmic Ca2+ 
level through efflux from the ER and Golgi complex (Aldabe et al. 1997). Increased 
cytoplasmic Ca2+ is closely related to efficient viral replication during infection (Cohen et 
al. 1979; Aldabe et al. 1997). Poliovirus protein 2BC inhibits the exocytic pathway and is 
proposed to be responsible for vesicle proliferation during polio infection (Barco and 
Carrasco 1995).  
In addition to membrane invagination, highly conserved enteroviral protein 2C is 
essential for various viral infection activities, including RNA binding (Pfister and 
Wimmer 1999), initiation of (-) sense RNA synthesis (Rodríguez and Carrasco 1995a), 
and viral replication. Membrane associated 2C has ATPase and GTPase activities, with 
three conserved motifs from superfamily III helicases (SF3 helicases) (Adams et al. 
2009). Similarly, the homo-oligomeric ring-like structures formed via SF3 helicases of 
2CATPase is essential for its ATPase activity (Adams et al. 2009). The 2C structure of 
enterovirus d71 is predicted to have three domains: N-terminus (stalk), C-terminus and 
helicase core domain (head) (Xia et al. 2015). Poliovirus 2C does not have helicase 
activity. However, the 2C protein of other enteroviruses such as enterovirus d71 and 
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Coxsackievirus, is able to unwind RNA and participate in virus-encoded RNA 
remodeling as an RNA chaperone, which is important for viral replication (Xia et al. 
2015).  
1.5.2 3AB/3A 
Protein 3A and its precursor 3AB are membrane-associated with a soluble N 
terminus and hydrophobic C terminus (Doedens et al. 1997; Strauss et al. 2003). Both 
play a crucial role in mediating assemblies of host cellular and viral proteins and lipids to 
form replication complexes during viral replication. NMR data showed that 3A exists as a 
symmetric dimer that consists of two α-helical hairpins. N and C termini are unstructured 
(Strauss et al. 2003). Expression of 3A alone in HeLa cells induces swollen ER 
membranes and dilated single-membrane structures with both tubular and fiddlehead 
configurations, which is also observed in the early stage of viral infection (Doedens et al. 
1997). Clusters of small ER-derived double-membraned vesicles are observed in cells 
expressing both 2BC and 3A.  The morphology of ER-derived double membraned 
vesicles resembles vesicles with an autophagic origin (Suhy et al. 2000). Of note, 3AB 
alone is able to invaginate single-membraned vesicles to form double-membraned 
vesicular structures when delivered into uninfected healthy HeLa cells (Wang et al. 2013) 
(Figure 1.5).  
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Figure 1.4 Morphological changes induced by viral proteins. (A) Morphological 
features of mock- infected cells at 4 hpi. The nucleus (N) and Golgi Apparatus (G) 
are apparent in the cytoplasm of mock-infected cells at 4 hpi (Suhy et al. 2000). (B) 
The infected cell is characterized by dominant populations of small single-
membraned vesicular clusters at 4 hpi (Suhy et al. 2000). (C) The infected cells have 
double-membraned vesicles at 5 hpi, pointed out by the black arrow (Schlegel et al. 
1996). (D) Transfection of 2C leads to the curled sheet-like structures that originate 
from the endoplasmic reticulum (Cho et al. 1994). (E) 3A expression alone results in 
tubular dilated single-membraned structures (Suhy et al. 2000). (F) Transfection of 
both 3A and 2C leads to small double-membraned clustered vesicles, similar to 
those observed in infected cells at 5 hpi (Suhy et al. 2000). All scale bars represent 1 
µm.   	
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Further roles of 3AB during infection have been shown by its colocalization with 
dsRNA throughout infection (A. L. Richards et al. 2014; Chen et al. 2015). 3AB recruits 
PI4Kinase to the replication complex and participates in cholesterol-trafficking. This 
leads to the generation of PI4P-enriched replication structures that contain cholesterol 
(Hsu et al. 2010; Ilnytska et al. 2013). In the early stage of infection, 3AB interacts with 
host protein GBF-1 to recruit replication complexes (Hsu et al. 2010).In the late stage of 
infection (6 hpi) 3AB has been found to interact with 2C (Natalya. Teterina et al. 2011), 
which indicates its multiple roles during infection. Recently, unconventional viral 
transmission has been observed for non-enveloped poliovirus and other enteroviruses 
(Chen et al. 2015). This viral transmission is mediated by PS-rich extracellular vesicle 
(Chen et al. 2015). 3AB colocalizes with PS in the late stage of infection. It is reasonable 
to guess that 3AB may participate in packing mature infectious poliovirus particles into 
PS enriched vesicles through membrane remodeling for the non-lytic transmission (Chen 
et al. 2015).   
		
20 
 
1.5.3 3CD/3D  
3CD is the precursor of 3C protease and 3D polymerase, and is a stable 
intermediate with distinct roles during viral infection. Although 3CD contains a 3D 
domain, it has no polymerase activity (Harris et al. 1992). Similar to 3D, the 3D domain 
of 3CD is characterized with a classic fingers-palm-thumb structure that is observed in 
many RNA-dependent polymerase. However, the first three residues of the N terminus of 
3D (inserted into a surface pocket in 3D through hydrogen bond interactions) are 
	
Figure 1.5 Viral protein 3AB-induced membrane invagination. (A) An 
electron micrograph of an ultrathin section (100 to 200 nm thickess) of 3AB-
transduced HeLa cells, stained with 3% uranyl acetate. The cytoplasmic 
membranous inclusions are pointed out by white arrows. The scale bar = 500 nm 
(Wang et al. 2013). (B) A cryo-electron micrograph of 3AB reconstituted 
proteoliposomes. Different “horseshoe” intermediates of double-membraned 
liposome formation were observed after 3AB reconstitution. The scale bar = 200 
nm (Wang et al. 2013).   	
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rearranged differently in the 3D domain of 3CD (rotated out of the pocket). This 
rearrangement is caused by a flexible seven-residue polypeptide that links the 3C and 3D 
domain of 3CD. It is suggested that changes in molecular flexibility may be responsible 
for lack of polymerase activity in 3CD (Marcotte et al. 2007). 3CD is the key factor that 
shifts viral translation to transcription and initiates viral replication. This is mediated 
through viral genome circularization (Harris et al. 1994). The circularization of 5’ and 3’ 
NTR is crucial for initiation of both (+) and (-) sense RNA replication (Herold and 
Andino 2001). 3CD, which interacts with the cellular poly-binding proteins (PCBPs) and 
poly(A)-binding protein, binds onto the secondary structure of genome stem-loop I at the 
5’ NTR and poly(A) tail of the 3’ NTR (Herold and Andino 2001). These interactions are 
involved in (+) RNA genome circularization. Moreover, 3CD can interact with 
heterogeneous nuclear ribonucleoprotein (hnRNP) that participates in pre-mRNA 
processing in normal cells (Brunner et al. 2005). Impairing the interaction between 
hnRNP and 3CD inhibits the synthesis of viral (+) sense RNA, probably in the initiation 
stage on (-) sense strands (Brunner et al. 2005). Interestingly, in the presence of 
polymerase 3D, binding of 3CD and 3A suffices for replicating the viral genome in vitro, 
independent of interactions with host proteins (Harris et al. 1994). Taken together, the 
interactions of 3CD with PCBPs, hnRNP, viral protein 3AB, and the 5’ and 3’ NTRs of 
(+) RNA are fundamental to the formation of viral replication machinery/complexes.  
Undoubtedly, the viral RNA-dependent RNA polymerase 3D that replicates the 
genome is the major component of the viral RNA replication complex. A 3D-V391L 
mutant has an impaired interaction with 3AB, but not with other viral or host proteins. 
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While 3D-V391L displays a temperature sensitivity and conditional defect in RNA 
synthesis, it has intact viral protein translation activity, which indicates the significance 
of viral protein interactions in viral replication (Hope et al. 1997). Later studies showed 
that 3AB recruits PI4Kinase (Hsu et al. 2010) and the interaction between 3AB and 3D is 
proposed to be the force that brings 3D onto the PI4P-enriched membranous replication 
complex (Jackson 2014; Altan-Bonnet 2017). Biochemical analysis and structural studies 
have shown the polymerase-polymerase interaction of poliovirus (Hobson et al. 2001). 
This oligomerization is proposed to be important for efficient template utilization (Pata et 
al. 1995; Hobson et al. 2001).  
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1.6 Viral Evolution and Roles in Virulence 
Evolution produces a change in the genetic properties of populations, driven by 
the selection of the host (Moya et al. 2000). In the history of organisms on the earth, 
living beings have experienced enormous genetic adaptations against brutal 
environmental selections to survive, and (+) sense RNA viruses are no exception. In 
order to survive, (+) sense RNA viruses have tangled with host defense mechanisms and 
replicate in diverse cellular environments and to pass through anatomic tissue restrictions 
such as the blood-brain barrier.  The adaptation tool that all viruses utilize is high 
mutation rates (Drake and Holland 1999) because RNA virus polymerases lack a 
proofreading function (Moya et al. 2000; Elena and Sanjuán 2005). Constantly created 
viral genetic variants are critical for fitness, survival (Elena and Sanjuán 2005) and more 
importantly, virulence (disease-producing and pathogenetic properties) (Korboukh et al. 
2014). An understanding of how genetic diversity of (+) sense RNA viruses impacts the 
outcome of infection and transmission will inform the development of antiviral therapies 
and vaccine strategies. Although faster adaption is accompanied by a frequent mutation 
rate, the vast majority of mutations are deleterious, thus hindering adaptation (Johnson 
and Barton 2002). Another mechanism of viral adaptation is recombination, when at least 
two viral genomes co-infect the same host cell and exchange genetic segments. The inter-
genomic recombination is most commonly used: the genetic brings beneficial mutations 
into the same genome while purging deleterious ones (Muller 1964; T. F. Cooper 2007; 
Pérez-Losada et al. 2015; Xiao et al. 2016).  
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1.6.1 Mutations and Virulence 
When an RNA virus infects a host cell, its viral genome is replicated and packed 
into a shell formed by capsid proteins, which generates numerous progeny viral particles. 
Due to a lack of a proofreading enzyme that assures fidelity during replication, an RNA 
virus population consists of an ensemble of related sequences, termed quasispecies, 
instead of a single genotype (Holland et al. 1992). It has been hypothesized that this trait 
allows RNA viruses to quickly select beneficial mutations because viral quasispecies are 
more likely to benefit from high mutation rates to evolve and adapt to new environments 
(Domingo 2000; Biebricher and Eigen 2005). Vignuzzi et al. (2006) tested this 
hypothesis by showing that a G64S mutant that replicates at wild-type level with its high 
fidelity polymerase, generates less genomic diversity and is unable to adapt to adverse 
environments. Infection of the central nervous system caused by G64S poliovirus was 
delayed and observed only at very high viral dose (Vignuzzi et al. 2006). This attenuated 
phenotype of G64S was completely reversed by treatments with chemical mutagens that 
impair the high fidelity of the polymerase, while retaining the G64S mutation. The data 
further supported the fact that quasispecies function as a group of interactive populations 
rather than a collection of diverse mutants (Vignuzzi et al. 2006). Similarly, another 
poliovirus polymerase mutatant H273R, with increased GMP misincorporation while 
replicating, leads to increased population diversity and viral infections strong enough to 
induce a protective immune response (Korboukh et al. 2014). Consistent with 
experimental data, a stochastic mathematical model developed by Schulte et al. (2015) 
creates computer stimulations of the number of polioviruses in an infected cell. The 
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model takes into account time and space constraints. It showed that new copies of the 
viral RNA are transcribed and copied to pass on distinct mutations to the next set of RNA 
copies. As a result, using the analogy of great-great-great daughter, the average virus 
released from an infected cell is genetically distinct from the original virus (Schulte et al. 
2015).  However, most mutations have deleterious fitness effects (Crotty et al. 2001; 
Johnson and Barton 2002; Korboukh et al. 2014). For example, Ribavirin, a mutagen, is 
used as antiviral nucleoside analog to force deleterious fitness effects by increasing the 
mutation rate. Low to intermediate concentration of Ribavirin leads to a Ribavirin-
resistant poliovirus population due to the emergence to the high-fidelity G64S poliovirus 
(Pfeiffer and Kirkegaard 2003). Another example is that the mutant H273R poliovirus 
polymerase fails to replicate in tissues in which the wild-type poliovirus persists, 
resulting in a reduction in H273R virulence (Korboukh et al. 2014). Clearly, there is a 
fine line between maximal virability and “error catastrophe” (Vignuzzi et al. 2006). 
Taken together, balancing these opposing factors is the key to an optimum rate at which 
the adaptation and virulence are both maximized. So far there have been two proposed 
avenues for evolutionary optimization: 1) in small populations, fitness evolution is 
achieved through making certain functions redundant; 2) recombination.  
1.6.2 Recombination and Virulence 
Reports of the existence of RNA recombination in picornaviruses dates back to 
the 1970s when both genetic and biochemical analysis showed that progenies displayed 
indisputable inheritance from both parents of viral proteins (Cooper 1968; Lake, Priston, 
and Slade 1975). Kirkegaard and Baltimore (1986) were the first scientists to investigate 
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the mechanism of RNA recombination. They proposed that there were two possible 
mechanisms: 1) RNA recombination occurs in the same pattern as DNA through base 
pairing, breaking, and rejoining; 2) viral RNA-dependent polymerase could jump and 
switch between multiple templates to generate a single RNA genome, called “copy 
choice”. The experimental data supported the “copy choice” model where both physical 
appearance and replication capacity of mother RNA are required (Kirkegaard and 
Baltimore 1986). Recently, Lowry et al. (2014) utilized a novel reverse genetic approach 
that isolates intermediate chimeric polioviruses that are characterized by extensive 
duplicated sequences at the recombination junction, the progeny of which lost duplicated 
sequences yet gained increased virulence. Supporting the “copy choice” model, the data 
further suggested a process in which in addition to initial viral recombination, viral RNAs 
undergo a process of resolution that includes deletion of extraneous sequences, which 
leads to a final optimized virulence (Lowry et al. 2014). 
The significance of recombination in viral fitness and virulence became more 
obvious as catastrophe could derive from numerous deleterious RNA mutations (Crotty et 
al. 2001; Johnson and Barton 2002; Korboukh et al. 2014). Later, a series of mutants of 
poliovirus polymerase were identified with distinct mutation rates (fidelity of 
polymerase), with or without the ability to undergo recombination (Xiao et al. 2016). 
Studying these mutants in acute infection showed that recombination ability is essential 
to enrich the beneficial population from deleterious mutations the in vitro cell culture 
study. The decreased virulence caused by impaired recombination was not reversed by 
increased mutation capacity of the polymerase in an animal infection study (Xiao et al. 
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2016). The interplay between recombination and mutation that leads to an accumulation 
of beneficial mutations, has contributed to vaccine-derived polio-infection (Stern et al. 
2017). The process is mediated through a series of initial substitutions of poliovirus viral 
protease (3C gene), RNA-dependent RNA polymerase (3D gene), and the 3’ UTR (Stern 
et al. 2017).   
1.7 Extracellular Vesicles and Roles in Viral Transmission 
The discovery of extracellular vesicles dates back to the 1980s. A series of 
publications pointed out the existence of membrane-bounded vesicles in blood (Crawford 
1971), urine (Wiggins et al. 1987), semen (Stegmayr and Ronquist 1982), breast milk 
(Admyre et al. 2007), cerebrospinal fluid (Chiasserini et al. 2014), and bile (Théry et al. 
2006). By definition, extracellular vesicles (EVs) are small membrane-enclosed sacs that 
are released from a variety of cells into the extracellular space. EVs display a strikingly 
wide range in size, ranging from 40 nm to 5 µM. The nomenclature of extracellular 
vesicle classification is a matter of debate. EVs can be categorized into many groups 
based on their size, function, and origin. The common categorization is based on the size 
(in diameter) (Kalra, Drummen, and Mathivanan 2016): 1) exosomes (40-100 nm, no 
more than 150 nm), 2) shedding microvesicles (100-1000 nm), and 3) apoptotic bodies 
(1-5 µM). While EVs were initially thought to be discarded “garbage bags” from cells, 
which is a major role assumed by apoptotic bodies, many EVs possess intricate and 
significant functions in intercellular communication as cell-to cell messengers (Valadi et 
al. 2007; Meckes and Raab-Traub 2011; Muralidharan-Chari et al. 2010; Kalra, 
Drummen, and Mathivanan 2016). By transporting proteins, RNAs, and mRNAs, 
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extracellular vesicles modulate cell proliferation (Proia et al. 2008), cell invasion 
(Muralidharan-Chari et al. 2009), gene regulation (Valadi et al. 2007), and immune 
regulation (Zitvogel et al. 1998; Zou 2005). EVs mediate progression of multiple 
pathological conditions, particularly in cancer (Muralidharan-Chari et al. 2010) and viral 
infections (Meckes and Raab-Traub 2011). The resemblance between EVs shed by virus-
infected cells and corresponding viruses themselves, especially enveloped viruses 
(Chahar, Bao, and Casola 2015; E. Nolte-’t Hoen et al. 2016), has aroused a deep interest 
in determining EVs pathogenic role in viral infections. Finally, discovery of EVs’ 
contributions to cell-to-cell viral transmission that utilized by non-enveloped viruses 
(Altan-Bonnet 2016) has blurred the definition of enveloped and non-enveloped viruses. 
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Figure 1.6 Biogenesis and release of shedding microvesicles and exosomes. 
Endocytic vesicles-ER-Golgi-plasma membrane axis/pathway is the major mechanism 
by which membrane-associated protein and lipid circulation and trafficking are 
conducted. Shedding microvesicles originate by direct budding from the plasma 
membrane whereas intraluminal vesicles (LVBs) comes from membrane invagination 
in early endosomes to form multivesicular bodies (MVBs). Some MVBs fuse with the 
plasma membrane to release exosomes via an ESCRT-dependent pathway. Other 
MVB contents are digested through fusion of MVBs with lysosomes. The point of 
divergence between these two vesicle-shedding processes is at early endosomes, 
mediated by clathrin-coated vesicles (CCVs) (modified from (Raposo and Stoorvogel 
2013)). 	
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1.7.1 Exosomes and Shedding Microvesicles  
Eukaryotic cells release heterogeneous populations of membrane-enclosed 
vesicles, and shedding microvesicles and exosomes are considered to be two major 
distinct classes. The distinction between these two classes manifests itself through 
morphology, biogenesis and release.  
Briefly, the maturation of early endosomes to late endosomes entails sorting and 
transporting macromolecules back and forth between the ER-Golgi-plasma network. 
During this process, some specific surface regions of endosomes experience inward 
budding, which generates multivesicular endosomes or multivesicular bodies (MVB). 
MVBs either fuse with lysosomes that are acidic compartments that digest and degrade 
the contents through enzymes such as lysosomal hydrolases, or fuse with the plasma 
membrane, to release their contents into extracellular space. These contents include intra-
luminal vesicles (LVBs), now termed exosomes when present in the extracellular milieu 
(Piper and Katzmann 2007). Therefore, exosomes, usually 40- to 100- nm in diameter, 
have been widely referred to as extracellular vesicles with an endosome origin (Figure 
1.6).  
Proteomic studies of exosomes have been extensively conducted. Exosomal 
protein markers are mainly comprised of the components involved in exosomal-
biogenesis and release. The Endosomal Sorting Complex Required for Transport 
(ESCRT) is comprised of over thirty proteins, along with associated proteins such as 
VPS4, VTA1, ALIX, assembled into four complexes (ESCRT -0, -I, -II, -III). ESCRT 
pathway is the major intracellular MVB biogenesis mechanism (Figure 1.6, (Théry et al. 
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2002)). By regulating the process of binding, sorting, clustering of ubiquitinylated 
proteins and receptors, ESCRT-complexes induce inward budding of nascent LVBs 
within MVBs. As a result, the ESCRT-dependent pathway often yields exosomes with a 
canonical marker TSG101, which is a recruited component of ESCRT-I (Théry et al. 
2002). Another major protein marker of exosomes is tetraspanins (CD9, CD82, CD63, 
CD81) that coordinate cytoskeletal-plasma membrane interactions that are responsible for 
intracellular MVB trafficking to the cell periphery to release vesicles outside (Simons and 
Raposo 2009).  
While exosomes usually assume a more uniform size that ranges from 40 to 100 
nm in diameter, shedding microvesicles appear to be more heterogeneous in size, ranging 
from 100 nm to 1 µM in diameter. Shedding microvesicles derive from outward budding 
of the plasma membrane, which is followed by a process of fission and release into the 
extracellular space (Meckes and Raab-Traub 2011) (Figure 1.6). It is understood that the 
enzymes involved in this process, include at least 1) an ATP-dependent flippase that 
preferentially transports phosphatidylserine and phosphatidylethanolamine to the 
cytosolic leaflet, 2) an ATP-independent flippase that preferentially transports 
phosphatidylserine to the cytosolic leaflet (Sune et al. 1987), 3) a floppase that is an 
ATP-dependent transporter to mediate the movement of phospholipids in the reverse 
direction, from the inner to the outer monolayer (Seigneuret and Devaux 1984), and 4) a 
scramblase that mediates the calcium-dependent non-specific bidirectional movement of 
phospholipids across the membrane (Bassé et al. 1996). All of these are enzymes that 
specialize in mediating phospholipid translocation to maintain the asymmetric lipid 
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composition at the plasma membrane. Not all plasma-membrane proteins are 
incorporated into shedding microvesicles, and the membrane composition of shedding 
microvesicles remains different from the parental cell. For example, while shedding 
microvesicles contain a very high level of phosphatidylserine (PS) on their outer 
membrane surface, PS is located at the inner membrane leaflet of cells (Muralidharan-
Chari et al. 2010). Of note, the binding interaction between exposed PS on shedding 
vesicles and the protein annexin-V, has been used to characterize and isolate these 
membrane vesicles (Dachary-Prigent et al. 1993; Chen et al. 2015). The absence of 
flippase in shedding microvesicles is probably responsible for PS exposure on secreted 
vesicles.  
1.7.2 Intercellular Messengers and Enveloped Viral Infection 
Although the discovery of extracellular vesicles dates back to the 1970s, it has 
only recently been appreciated that extracellular vesicles present unique and intriguing 
biological functions as cell-to-cell messengers (Meckes and Raab-Traub 2011; 
Muralidharan-Chari et al. 2010; Kalra, Drummen, and Mathivanan 2016). In 1996, 
Raposo et al. (1996) showed an exosome-mediated adaptive immune response induced by 
Epstein-Barr virus (EBV)-transformed B-lymphocytes, which brought attention to the 
relationship between extracellular vesicles and viral infection.  
The similarity between extracellular vesicles and enveloped viruses is striking 
(Anderson, Kashanchi, and Jacobson 2016). In particular, retroviruses are thought to be a 
close relative to extracellular vesicles (Nolte-’t Hoen et al. 2016). This leads to Trojan 
exosome hypothesis in retroviral transmission (Gould, Booth, and Hildreth 2003): like 
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extracellular vesicles, enveloped viruses exploit pre-existing intracellular vesicle 
trafficking (Gould, Booth, and Hildreth 2003) for formation of infectious particles and 
content cell-to-cell transmission. When binding to corresponding receptors, enveloped 
viruses are internalized, and trigger specific reactions in the recipient cell. Further, in 
addition to transporting bioactive proteins and lipids, the discovery of active viral genetic 
materials being transported through extracellular vesicles, mainly small RNAs (Valadi et 
al. 2007; Nolte-’t Hoen et al. 2012), has even blurred the boundary between enveloped 
virions and EVs. The transport of bioactive genetic materials is predominately an active 
sorting of specific RNA processes that utilizes, and depends on, defined RNA-binding 
proteins (Villarroya-Beltri et al. 2013). In other words, in the spectrum of extracellular 
vesicles, enveloped viruses could be considered as one specific type of extracellular 
vesicle that is viral replication-capable. Other types of extracellular vesicles display no 
indigenous infectivity but retain the capability of affecting viral infection (Dreux et al. 
2012; Narayanan et al. 2013).  
Fusion of extracellular vesicles with recipient cells allows transported bioactive 
macromolecules to exert effects on a targeted cells’ function. A recent study reported that 
selectively released exosomes mediate an antiviral immunity response in EBV latent-
infected dendritic cells through the transfer of RNA fragments (Baglio et al. 2016). Many 
recent studies on Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), 
Human T-cell Lymphotropic Virus (HTLV), and Dengue Virus (DENV) have proved that 
exosomes released from infected cells spread or limit an infection by transporting many 
regulatory host and viral proteins and RNAs. Studies on HCV-infection (Dreux et al. 
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2012; Longatti, Boyd, and Chisari 2015) showed that shed exosomes are able to establish 
productive infection through delivery of a complete HCV-genome.  
 
	
Figure 1.7 Enteroviral non-lytic viral transmission pathway. The cartoon model 
depicts non-lytic enteroviral cell-to-cell transmission of vesicles. Clusters of multiple 
viral particles are captured by PS-enriched double-membraned organelles that are 
associated with viral replication membranous structures. These double-membraned 
vesicles fuse with the plasma membrane and release a single-membraned PS-enriched 
vesicle loaded with multiple virions into the extracellular space. These virion-
containing vesicles are internalized via a PS-lipid and viral receptor-dependent 
mechanism into the recipient cell. The collective transfer of multiple viral genomes 
confers increased infectivity (modified from (Chen et al. 2015)).   	
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1.7.3 Intercellular Messenger and Non-enveloped Viral Infection 
Traditionally, viruses have been classified as 1) “non-lytic” and “enveloped” 
(capable of exiting host cells without dismantling the plasma membrane), and 2) “lytic” 
and “non-enveloped” (exiting the host cell with concommitant cell lysis). The presence or 
absence of a lipid-bilayer membrane profoundly affects viral stability, transmission and 
immune responces. While non-enveloped viruses, conventionally, are released into the 
extracellular space upon cell lysis, virus-induced extracellular vesicles can carry mature 
virions from one cell to another without dismantling the plasma membrane (Figure 1.7). 
It has been strongly suggested non-enveloped viruses exploit non-lytic viral transmission 
through extracellular vesicles without killing infected cells (Colbère-Garapin et al. 1989; 
Lloyd and Bovee 1993). Electron micrographs of rhinovirus 14-infected HeLa cells show 
a viral-capsid-containing vesicle that was to detach from the plasma membrane of an 
infected cell, as well as viral-capsid-containing extracellular vesicles proximal to infected 
cells (Jackson et al. 2005). The first non-enveloped assembled viral particle that was 
clearly seen wrapped inside a membranous vesicle (Figure 1.8) is hepatitis A virus 
(HAV) in 2013 (Feng et al. 2013). HAV is a non-enveloped, positive-sense, single-
stranded RNA virus, which belongs to the big and diverse Picornaviridae family. The 
membrane-surrounded virion is called enveloped HAV (eHAV), which is shed into the 
extracellular space and infectious. Furthermore, eHAV can be easily separated from 
HAV using neutralizing antibodies against capsid proteins (Feng et al. 2013). In their 
experiments, assembled HAV particles were localized to MVBs in infected cells and 
depletion of ESCRT proteins prevented the release of eHAVs, suggesting that exosome 
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biogenesis pathways were being exploited. Likewise, various real-time tracking 
microscopy and biochemical analysis showed that poliovirus, Coxsackievirus, and 
rhinovirus have been reported to utilize this non-lytic viral transmission pathway (Bird et 
al. 2014; Robinson et al. 2014; Chen et al. 2015). Electron microscopy (Figure 1.8) 
showed multiple virions within a double-membraned vesicle inside infected cells and 
within a single-membraned vesicle in the extracellular space. Disrupting or stimulating 
autophagy leads to blocked or enhanced the non-lytic release of poliovirus, respectively 
(Jackson et al. 2005). Furthermore, infectious extracellular vesicles containing multiple 
virions are enriched in PS. PS is a cofactor for extracellular vesicle-mediated viral 
infection, as masking of the PS on the surface of these vesicles by annexin-V inhibits 
viral infection of the host cell in a dose-dependent manner. Chen et al. (2015) further 
found that the vesicle-mediated poliovirus transmission is dependent on the surface PS of 
the vesicle and the presence of virus-specific receptors on the host cell. The mechanism 
whereby the vesicles containing virions infect recipient cells is unclear.  
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Interestingly, the features of virion-containing extracellular vesicles appear to 
distinct for each virus in the family Picornaviridae (Whitton, Cornell, and Feuer 2005). 
										
	
1.8 Non-enveloped Virions Surrounded by Membrane. (A-H) Electron 
micrographs of negatively stained virion-containing vesicles in infected cells or in the 
extracellular space. (A-B) Single-membraned extracellular vesicles with one or 
multiple virions enclosed inside were shed from HAV-infected cells (Feng et al. 
2013). (C-D) Extracellular vesicles from Coxsackievirus-infected cells (Robinson et 
al. 2014). (E-F) Virion-like particles were enclosed by double-membraned vesicles 
within poliovirus-infected cells at 6-7 hpi (Chen et al. 2015). (G-H) Extracellular 
vesicles from poliovirus-infected cells (Chen et al. 2015). The scale bar = 50 nm (A-
B), 100 nm (C-D), 500 nm (E), 200 nm (F), 100 nm (G-H).  	
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Extracellular vesicles released from Coxsackievirus-infected cells seem smaller and more 
homogeneous in size than those from poliovirus-infected cells. The detection of flotillin-
1, an exosomal marker (Inal and Jorfi 2013; Robinson et al. 2014), on Coxsackievirus-
derived extracellular vesicles suggests a possible involvement of the exosomal pathway 
in their biogenesis. These exosomes from Coxsackievirus-infected cells carry autophagic 
protein marker lipidated LC 3. Similarly, autophagy is related to the release of virion-
containing extracellular vesicles from poliovirus-infected cells. siRNA-mediated 
depletion of the autophagy membrane protein LC 3 resulted in a decrease in nonlytic 
intercellular viral transfer, which could be reversed by over-activation of the autophagy 
pathway (Bird et al. 2014). 
1.8 Goal of the Thesis 
Using poliovirus as a prototype, our goal is to elucidate how an enterovirus 
utilizes the unconventional extracellular vesicle-mediated viral transmission pathway to 
increase infectivity. First, complementary biochemical and structural analyses were used 
to clarify the biological and physical features of virion-containing infectious extracellular 
vesicles (IEVs). Second, we took an in vitro approach to shed light on the identification 
of key viral proteins that participate in the biogenesis of IEVs in poliovirus-infected cells.   
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2. Materials & Methods 
2.1 Cell culture and Poliovirus-infection of HeLa Cells 
HeLa cells, a kind gift from the laboratory of Dr. William T. Jackson, were used 
because HeLa  cells have a long history of work with poliovirus. HeLa cells were 
cultured in low-glucose DMEM medium supplemented with 5% fetal calf serum (FBS) 
and 1% penicillin-streptomycin-glutamine (from Atlanta Biologicals, Cat.S11150; 
ThermoFisher, Cat.10378016, respectively). Cells were maintained in a 37 °C humidified 
atmosphere (5% CO2), and then subcultured onto culture dishes with a 60 to 80 % 
confluent, a uniform monolayer for polio-infection.  Mahoney type poliovirus was 
provided by the laboratory of Dr. Karla Kirkegaard (Stanford University). This virus 
solution was titrated by classic plaque assay (see below) using HeLa cells at 37 °C, for 48 
hours and stored at -80 °C. 
After being washed once with PBS + (PBS supplemented with 0.01 mg/ml MgCl2 
and 0.01 mg/ml CaCl2), cells were infected either with poliovirus-containing PBS+ at a 
multiplicity of 30 virions per cell, or an equivalent volume of PBS + for 30 minutes at 37 
°C. Then, unbound viruses were removed by aspiration and rinsing in PBS +, followed by 
the appropriate time of infection in DMEM at 37 °C. The time point defined as 0 hpi 
began at the termination of the 30-minute incubation. At different post-infection time 
points, cells and/or the supernatant were collected for subsequent analyses.  
2.2 Collection and Purification of PS-enriched IEVs 
IEVs were collected and purified from the supernatant of poliovirus-infected 
HeLa cells at 8 hpi.  The supernatant underwent a series of centrifugation steps that 
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started at 150 x g for 15 minutes at room temperature to remove cell debris. Then the 
supernatant was centrifuged at 10,000 x g at 4 °C, to collect the extracellular vesicles 
with a size range of 100 nm to 1 µm in diameter. Both the supernatant and pellet were 
saved. This size range was chosen based on the literature (Chen et al. 2015). It has been 
reported that IEVs are coated with phosphatidylserine (PS) on their surface, which 
interacts with protein annexin-V (Chen et al. 2015). In order to enrich IEVs, the pellet 
was resuspended in 80 µl of 1X binding buffer and 20 µl of annexin-V microbeads, from 
the annexin-V microbead kit (Miltenyi Biotec, Cat. 130-090-201). Briefly, the PS-
exposing vesicles were enriched by magnetic enrichment using annexin-V microbeads. 
Vesicles that were incubated with annexin-V passed through a MACS Column placed in 
the magnetic field of a MACS Seperator. The annexin-V labeled vesicles were retained in 
the column while the unlabeled vesicles were washed away. The magnetically retained 
vesicles were eluted from the column in the absence of the magnetic field. The eluted PS-
enriched vesicles were spun down and resuspended in the appropriate amount of 1X PBS 
for subsequent assays. The MEVs underwent the same steps. 
2.3 Collection and Purification of CD9 Positive Exosomes 
The supernatant from the 10,000 x g centrifugation was then further centrifuged at 
100,000 x g to spin down the exosomes with an upper diameter of 100 nm. The pellet 
was resuspended in 500 µl of 1X PBS and mixed with 100 µl of Exoquick-TC (System 
Biosciences Inc.). The mixture was incubated overnight at 4 °C, and the exosomes were 
collected through a 30-minute centrifugation at 1,500 x g. In order to enrich CD9 positive 
exosomes, the collected exosomes were incubated with the 1X washing buffer 
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supplemented with CD9 antibody-coated magnetic beads (CD9 Exo-Flow Exosome 
Purification Kit, System Biosciences, Cat. EXOTC10A-1). These beads are designed to 
capture CD9 positive exosomes because they are streptavidin magnetic beads coupled 
with biotinylated CD9 antibody. The unlabeled exosomes were removed while the 
labeled ones were retained on the wall of the centrifuge tube facing the magnetic stand. 
Following the user manual, the CD9 positive exosomes were collected and ready for 
subsequent assays. If the CD9 positive exosomes were applied onto HeLa cells for 
infectivity assays, the magnetic beads were removed per the manual. Exosomes from the 
mocked-infected sample went through the same steps.  
2.4 Sample Preparation of the Intact and Broken IEVs/MEVs 
IEVs and MEVs were freeze-thawed three times to break the membrane of 
vesicles. In order to fully destroy the protection from vesicular structures, freeze-thawed 
vesicles were incubated with 1 % sodium deoxycholate (300 µg/ml) on ice for 45 
minutes. Then the sample was treated with a 1-hour RNAse incubation (600 µg/ml, 
Sigma Cat. 10109142001) at 37 °C.  
2.5 Sample Preparation for Immunoblotting 
Infected cells at different HPIs were scraped with a cell scraper into 1 X PBS, and 
then centrifuged at 150 x g for 15 minutes. The pellet was resuspended in RIPA buffer 
(50 mM Tris/HCl pH 7.4, 75 mM NaCl, 1 mM EDTA, 1% NP-40, 0.25% sodium 
deoxycholate, 0.1% sodium dodecyl-sulfate) with protease inhibitor cocktail diluted 
1:200 (Sigma Cat. P1860, containing Aprotinin, Bestatin, E-64, Leupeptin, and Pepstatin 
A). The resuspended pellet was incubated on a shaker at 4 °C for 30 minutes, followed by 
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a centrifugation at 16,000 x g for 20 minutes. The supernatant was saved and mixed with 
6 X SDS-PAGE (100 mM Tris pH 6.8, 20% glycerol, 4% SDS, 0.2% Bromophenol blue, 
200 mM DTT) or Tricine-SDS loading buffer (12 % SDS, 6% mercaptoethanol, 30 % 
glycerol, 0.05% Coomassive blue, 150 mM Tris/HCl, pH 7) to make a final 1X mixture. 
The mixture was boiled for 10 minutes at 100 °C, and stored at – 20 °C. Thawed samples 
were boiled for 5 minutes at 100 °C prior to electrophoresis.  
Cell lysates were run on a 15% SDS-PAGE at 120 V, or Tricine-SDS gel at 30 V. 
To perform Western Blotting, the gel was subsequently semi-dry transferred onto a 
nitrocellulose membrane at 150 V for 15 minutes. The membrane was blocked with 
TBST (50 mM Tris pH 7.4, 150 mM NaCl, 0.05 % Tween-20) containing 5% powdered 
milk (blocking buffer) for 2 hours at room temperature to reduce non-specific antibody 
binding. After blocking, the membrane was incubated overnight at 4 °C with the blocking 
buffer supplemented with anti-3Dpol rabbit IgG (Cocalico Biologicals, 1 mg/ml, diluted 
at 1:1k), or anti-2C rabbit IgG (Cocalico Biologicals, 1 mg/ml, diluted at 1: 1k) or anti-
3A rabbit IgG (Biomatic, 0.6 mg/ml, at 1:500).  Excessive primary antibodies were 
washed away after three times rinse in TBST, 5 minutes each. The membrane was then 
incubated with the blocking buffer supplemented with a secondary HRP-conjugated goat 
anti-rabbit IgG antibody (Invitrogen) for 45 minutes at room temperature. Prior to the 
development with Western Lightning ECL-Plus reagents (Perkin-Elmer), the membrane 
was washed 4 times with TBST, 5 minutes each.  
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2.6 Sample Preparation for RT-qPCR  
RNAs from the whole infected cells and extracellular vesicles that were collected 
via 10 k x g centrifugation, were extracted using RNeasy Plus Mini Kit (Qiagen, Cat. 
74134). Extracted RNAs were eluted in 30 µl of nuclease-free water and stored at -80 °C.  
The full length poliovirus genome and its (-) stranded template were amplified in 
duplicate through two-step RT-qPCR. Briefly, the cDNAs were synthesized in a 
SuperScript III RT (Life Technology, Cat.18080-093) system using RT primers listed in 
Table 1 (Schulte et al. 2015). Tag primer was used to increase its binding specificity and 
efficiency. The qPCR was performed using Fast SYBR Green Master mix system (Life 
Technology, Cat.4385610) with qPCR primers listed in Table 1.  
The housekeeping gene GAPDH was used for normalization. The detection was 
performed in a two-step RT-qPCR using High Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems, 4374966) and Fast SYBR Green Master mix system (Life 
Technology). 
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Tabel 1. RT-qPCR primers 
Primer Name Sequence 
PV (+) stranded_RT GGCCGTCATGGTGGCGAATAATGTGATGGATCCGG
GGGTAGCG 
PV (-) stranded_RT GGCCGTCATGGTGGCGAATAACATGGCAGCCCCGG
AACAGG 
PV (+) stranded_F CATGGCAGCCCCGGAACAGG 
PV (-) stranded_R TGTGATGGATCCGGGGGTAGCG 
PV Tag GGCCGTCATGGTGGCGAATAA 
GAPDH_F GCATCCTGGGCTACACTGAG 
GAPDH_R CCCTGTTGCTGTAGCCAAAT 
 
2.7 Negative Staining  
Copper grids (400 mesh, Ted Pella Inc. Cat. G400) with a continuous carbon film 
were glow-discharged for 30 seconds to render the surface hydrophilic. Sample (5-7 µl) 
mixed with 2% glutaraldehyde at the ratio of 1:1 was applied onto the grids and 
incubated at room temperature for 10 minutes. After the incubation, the grid was washed 
on top of three 50 µl drops of 1 X PBS, followed by two consecutive 15 µl drops of 1% 
uranyl acetate for 10 seconds, and then a final 15 µl drop of 1% uranyl acetate for 30 
seconds. The grid was then blotted with filter paper and dried in the air.  
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2.8 Sample Preparation for Cryo-electron Microscopy 
A collection of post-column MEVs or IEVs was prepared freshly. C-Flat 4/2 
holey carbon grids (Protochips, Cat.CF-4/2-2C-50) were used. To stabilize larger vesicles 
with a diameter ≥ 300 nm on the grid, an extra layer of carbon was added on the grid 
surface, prior to the cryo-preparation. A 3 µl sample of MEVs or IEVs was applied onto 
the freshly glow-discharged, carbon coated grids. If the samples were to be prepared for 
electron tomography, 0.5 µl of 5-nm fiducial gold (Ted Pella Inc. Cat.82150-5) was 
applied to the sample drop and incubated together for 1.5 minutes at 10 °C, at 100% 
humidity. The grid was then quickly blotted for various periods of time to obtain a 
suitable ice thickness, and quickly plunge-frozen in liquid ethane. The entire plunge-
freezing was done in the Vitrobot Mark III (FEI Oregon) system. Afterwards, the gird 
was stored in liquid nitrogen.  
2.9 Imaging of Cryo-electron Microscopy and Tomography 
Cryo-electron microscopy was performed on Philips CM12 and Tecnai F20 
(TF20) electron microscopes. The cryo-prepared grid was either imaged at 100 kV on the 
CM12 (TVIPS CCD camera, pixel size of 6.808 Å, defocus ranged from -0.6 to -0.7 µm, 
with an electron dose ≤ 30 electrons per Å), or at 160 kV, on the TF 20 (TVIPS CMOS 
camera, binning factor 2, binned pixel size of 8.280 Å, defocus ranged from -3 to -4 µm, 
with an electron dose ≤ 30 electrons per Å).  
Cryotomography was performed on three microscopes:  1) TF20 at BUSM, 
Boston, MA; 2) JEOL JEM2200FS at Baylor College of Medicine, Houston, TX; and 3) 
Titan Krios at Florida State University, Tallahassee, FL). On the TF20, an Oxford model 
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cryo-holder was used. The digital images were recorded as a single axis tilt series (TVIPS 
CMOS camera, binning factor 2, binned pixel size of 8.280 Å) over a - 54° to + 54° 
typical tilt range with an angle increment of 2° at a defocus of -4 µm, with a total electron 
dose ≤ 100 electrons per Å using serialEM. On the JEM2200FS (in-column energy filter, 
200 kV), the grid was imaged under a 5k x 3k Direct Electron Detector (DE20) with a 
pixel size of 4.01 Å and defocus of -4 µm, at 24 frames per second. The total cumulative 
dose was ≤ 70 electrons per Å2. The typical tilt range was from ~ -60° to + 60° using 
serialEM.  Alternatively, the girds were imaged on the Titan Krios (300 kV) equipped 
with a 5k x 3k DE20 camera (pixel size of 2.601 Å) at 5 frames per second.  
2.10 Immunolabeling of Viral Protein 3AB on IEVs 
The sample pellets were resuspended in 2% glutaraldehyde, 6 µl of which was 
applied to a carbon-coated nickel grid, and incubated at room temperature for 10 minutes. 
For immunolabeling, all incubation steps were performed by floating the grids on top of 
drops, at 4°C using pre-cooled buffers except the final negative staining step. After 
sample adsorption, the grids were incubated with two 50 µl drops of DPBS (ATCC 
Cat.30-2200) freshly completed with 20 mM glycine for 10 minutes to remove the 
excessive glutaraldehyde. The grids were then transferred to a 50 µl drop of casein 
blocking buffer (ThermoFisher Cat.37528, completed with 2% BSA, 0.2% ovalbumin, 
0.02% sodium azide) for 30 minutes. The primary rabbit polyclonal antibody against the 
poliovirus protein 3A sequence (KDLKIDIKTSPPPEC) (Biomatik, 0.6 mg/ml) was 
diluted 1: 50 in the blocking buffer. The grids were incubated with the primary antibody 
overnight.  
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Excessive primary antibody was removed by transferring the grids over five 100 
µl drops of DPBS with a 10-minute incubation time per drop. The secondary antibody—
goat anti-rabbit IgG gold-labeled antibody (Invitrogen, #R6394)—was prepared by 
dilution of 1: 100 in the blocking buffer. The grid was then incubated with the diluted 
secondary antibody solution for 90 minutes, followed by a washing step of five 100 µl 
drops of DPBS with 10-minute incubation per drop. At room temperature, staining was 
performed by transferring the grids to two consecutive 30 µl drops of 1% uranyl acetate, 
15 second incubation each drop, then one last 30 µl drop of 1% uranyl acetate for 1 
minute before blotting on filter paper.  
2.11 Image Processing and Tomography Reconstruction 
 All tomograms were reconstructed using the IMOD software package (Kremer, 
Mastronarde, and McIntosh 1996). Volume averaging was performed using PEET 
software (Nicastro et al. 2006). This includes the virions packaged inside the IEVs and 
membrane-associated “head-stalk” like proteins on the IEVs. All surface rendering 
models were generated from smoothed tomograms (Nicastro et al. 2006). The 3D surface 
model of virions inside IEVs was rendered through averaged and low pass filtered sub-
volumes from smoothed tomograms. Nonlinear anisotropic diffusion (NAD) filtering was 
used to generate the 3D surface models of inner thread-like structures in the IEVs with 
better continuity and less noise.  
 
2.12 Expression and Purification of Viral Protein 3AB 
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Viral Protein 3AB was expressed from a bacterial expression construct 
pT7lac3AB that encodes the full length of 3AB (Richards and Ehrenfeld 1998; Wang et 
al. 2013) (obtained from Dr. Karla Kirkegaard’s lab, Stanford University School of 
Medicine) in an E coli BL21 system, and purified using a published protocol from (Wang 
et al. 2013). E coli transformed with 3AB plasmid, were inoculated into M9 medium at 
37 °C and grown to an OD600 = 0.8. Expression was induced by addition of 0.1% 0.5 M 
IPTG, followed by an overnight incubation (less than 16 hours) in a shaker at 20 °C.   
The overnight culture was harvested and resuspended in cold buffer A (50 mM 
Tris pH 7.6, 100 mM NaCl, 1 mM EDTA, 5% glycerol) freshly supplemented with 1 mM 
DTT and protease inhibitor cocktail (Thermo Fisher Scientific #78430). All subsequent 
procedures were carried out at 4 °C or on ice. The cells were broken open by probe 
sonication for 10 minutes on ice. After a 20 minute spin at 20,000 x g to remove intact 
cells, the protein 3AB-containing supernatant was centrifuged at 100,000 x g for 2 hours. 
The resultant pellet was washed once in buffer A, resuspended, and then centrifuged 
again at 100,000 x g for 1 hour. The pellet was resuspended with buffer 1A (buffer A 
plus 0.5% NP-40) and rotated overnight. After a 1 hour centrifugation at 100,000 x g, the 
solution was dialyzed against buffer D (0.1% NP-40, 25 mM Tris pH 8.0, 10 mM NaCl, 1 
mM EDTA, 5% glycerol) freshly supplemented with 1 mM DTT and protease inhibitor 
cocktail, using a dialysis tubing with 3500 molecular weight cut-off, for 2 hours per 
buffer change, two rounds in total. After a 10-minute centrifugation at 20,000 x g to 
remove the precipitated contaminants, the solute was diluted 5-fold with freshly 
supplemented buffer D and applied onto a 5 ml DEAE anion exchange column (Bio-Rad) 
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equilibrated with supplemented buffer D. Proteins were eluted based on the salt 
concentration of the buffer. The protein that flowed through the column was collected 
and concentrated with a Vivaspin 20 3K MWCO PES membrane filter unit by 
centrifugation at 2,800 x g until the remaining solution was about 5 ml.  
The concentrated solution was diluted 5-fold with buffer DS (0.1% NP-40, 25 
mM MOPS pH 7.2, 5 mM NaCl, 1 mM EDTA, 5% glycerol) freshly supplemented with 
1 mM DTT and protease inhibitor cocktail. The second chromatographic purification was 
implemented with a cation-exchange S-Sepharose fast flow column (Bio-Rad). The 
diluted solution was loaded onto a 5 ml S-Sepharose column equilibrated with buffer S-
10 (Buffer DS with 10 mM NaCl), followed by a wash using buffer S-100 (Buffer DS 
with 100 mM NaCl). The bound protein was eluted with buffer S-200 (Buffer DS with 
200 mM NaCl). A UV detector was used to monitor proteins in the eluent. The protein-
containing fraction was further identified using Tricine-SDS gel electrophoresis. Glycerol 
was added to a final concentration of 10% in the protein-containing fraction and was 
stored at -80 °C.  
2.13 PI4P-containing Liposome Preparation by Extrusion 
L-α-phosphatidylinositol-4-phosphate (PI4P, Brain, Porcine), L-α-
phosphatidylserine (PS, Brain, Porcine), L-α-phosphatidylcholine (PC, Brain, Porcine), 
L-α-phosphatidylethanolamine (PE, Egg, Chicken), all from Avanti Polar Lipids 
(Alabaster, AL), were mixed at the indicated molar ratio (PC: PE: PI4P: PS = 10: 3: 1:1) 
and quickly dried under a stream of N2 gas. The dried film was further dried under 
vacuum for a minimum of overnight at 4 °C. The dried film was hydrated to a final 
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concentration of 1 mg/ml in HEPES-buffered saline (50 mM HEPES, pH 7.5, 100 mM 
NaCl, 5 mM MgCl2) for 1 hour at 32-35 °C with shaking. The resulting hydrated mixture 
was downsized through three cycles of freeze-thaw, two rounds of 10-second probe-
sonication, and 11-pass extrusion through a polycarbonate membrane with a pore size of 
200 nm. The size of vesicles was examined using electron microscopy of negatively 
stained samples, while cryo-EM was used to determine whether unilamellar vesicle 
formation was achieved.  
2.14 Fluorescent Spectrometry of 3AB-induced Membrane Remodeling 
Purified 3AB protein was diluted with buffer S200 and added to freshly made 
liposomes to a final concentration of 0.05 µM in the liposome solution that has 500 µM 
phospholipids, for appropriate periods of incubation at 37 °C. Rhodamine Red-X 
fluorescent secondary antibody (“Rhodamine”; Invitrogen, 2 mg/ml) was diluted to 
1:1600. Diluted Rhodamine was added to 3AB-incorporated liposomes in two different 
forms: 1) the whole Rhodamine-3AB-lipidsomes mixture was incubated for appropriate 
periods of incubation at 37 °C; 2) After appropriate periods of 3AB-lipidsome incubation, 
Rhodamine was added into the mixture for another 2 hour incubation. Then, the mixture 
was washed once to remove any free floating Rhodamine prior to the measurement of 
fluorescent signals from antibodies that were entrapped within the 3AB-incorporated 
liposomes, using spectrometry (excitation wavelength: 540 nm; emission wavelength: 
625 nm). All results were repeated ≥ 3 times.  
2.15 Sample Preparation for Mass Spectrometry 
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IEVs and CD9 positive exosomes from infected cells at 8 hpi were collected as 
stated above. Collected vesicles were sonicated in the ice-water bath for 4 minutes and 
incubated with 2,2,2,-Trifluoroethanol (TFE) (Sigma, #T63002) in a volume ratio of 1 to 
1, for 2 hours at 60 °C with shaking. The denatured and fixed samples were than cooled 
down to the room temperature (RT). (From this point on, the preparation was done by 
Deborah Chang, BUSM) Then ammonium bicarbonate and DTT were added to the 
mixture to a final ambic concentration of 50 mM, DTT concentration of 5 mM, prior to a 
30 minute incubation at 60 °C. Isodoacetamide (IAM) was then added to the mixture at a 
final concentration of 10 mM for a 30 minute incubation at RT in the dark. The same 
amount of DTT was added afterwards to quench excessive IAM. The stock solution was 
diluted with water (3 to 1) to make a final TFE concentration of 5% to raise pH for 
trypsin digestion. Fresh trypsin was added at the volume ratio of 1 to 30 of enzyme to 
substrate, followed by an overnight incubation at 37 °C. The next day, neat formic acid 
was added to lower the pH and quench trypsin digestion. The digested sample was 
cleaned by running through a C18 column and MALDI. After the clean-up, the sample 
was ready to run on LC-MS.  
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3. Biochemical and Structural Studies of Released Extracellular Vesicles  
3.1 Introduction 
The presence or absence of an outmost lipid bilayer determines distinct features of 
enveloped and non-enveloped viruses in virulence and viral transmission. The envelope 
acquired by enveloped, positive (+) sense RNA viruses such as Hepatitis C virus (HCV) 
and Dengue virus (DENV) allows viruses to exit infected cells without killing the host, 
and to spread to neighboring cells in a receptor-independent pathway. To accomplish this, 
enveloped viruses hijack the intracellular vesicular trafficking network in infected cells 
(Gould et al. 2003; Valadi et al. 2007; Nolte-’t Hoen et al. 2012). Extracellular vesicles 
from virus-infected cells modulate cell-to-cell communication through functional proteins 
and genetic materials (Villarroya-Beltri et al. 2013; Dreux et al. 2012; Narayanan et al. 
2013). In one case, HCV-RNA-containing exosomes released from HCV-permissive 
(capable of replicating) cells activate the immunostimulatory response of neighboring 
HCV-nonpermissive dendritic cells to hinder viral replication in HCV-permissive cells 
(Dreux et al. 2012). In another case, exosomes transporting replication-competent 
subgenomic RNA of HCV are capable of establishing viral replication in HCV-
permissive cells (Longatti et al. 2015).  
In contrast, for non-enveloped (+) sense RNA viruses such as enteroviruses (e.g. 
poliovirus, Coxsackievirus), the cell-to-cell spread was traditionally thought to occur 
when the cell membrane is dismantled by lysis. The topology of non-enveloped viruses 
does not enable them to penetrate through the plasma membrane without cell lysis. 
However, evidences of non-lytic viral exit and transmission continue to accumulate. 
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Time-lapse microscopy, fluorescent timer tracking, and single-cell analysis, show that 
clusters of enteroviral particles, such as poliovirus, rhinoviruses, and Coxsackievirus can 
be enclosed within a single-membraned phosphatidylserine (PS)-enriched vesicle, to aid 
cell to cell transmission in the absence of cell lysis (Bird et al. 2014; Robinson et al. 2014; 
Chen et al. 2015). In infected cells, PS-enriched vesicles colocalize with viral replication 
complexes wherein the RNA genomes, essential viral replication proteins, and 
membranous structures are concentrated (Chen et al. 2015). More importantly, virions 
transported through extracellular vesicles are more infectious than free virions (Robinson 
et al. 2014; Chen et al. 2015).  
Transmission electron microscopy (EM) has been considered one of the most 
reliable technique to study cellular vesicular trafficking and viral infection (Jackson 
2014; Rossignol et al. 2015). Two-dimensional (2D) images of negatively-stained 
extracellular vesicles have undoubtedly demonstrated the existence of a novel non-lytic 
transmission pathway (Robinson et al. 2014; Chen et al. 2015). However, potential 
artifacts from fixation and dehydration of negative stain may limit our understanding of 
the morphology of virion-containing vesicles (Maunsbach and Afzelius 1999; Afzelius 
and Maunsbach 2004).  For example, cryo-EM, a technique that visualizes frozen 
hydrated samples, shows that exosomes are spherical (Graça Raposo and Stoorvogel 
2013), rather than a cup-shaped appearance (Raposo et al. 1996). Furthermore, almost all 
cellular activities require extensive molecular assemblies through which unique spatial 
organization is achieved. In EM, image projections are collected, wherein distinct 
information from all heights of the specimen is collapsed onto a single plane as a 
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projection. Although 2D projections provide a general view of biological activities, three-
dimensional (3D) structural analysis is irreplaceable as it provides a way to determine the 
architecture of marcromolecular assemblies (Lučič et al. 2013). A tilt series of 2D EM 
images of the specimen contain object information spanning a large but not complete 
angular rang (due to physical limitations), even with double-axis tilt collection. Based on 
the back-projection algorithm, the spatial distribution of density in a reconstruction is 
proportional to the original density of specimen (Frank 1992; Subramaniam et al. 2003). 
These are the fundamental principles of electron tomography (ET) and 3D reconstruction. 
ET and 3D reconstruction have proven to be a powerful tool for studying 3D 
macromolecular assemblies and cellular activities at high resolution (Nicastro et al. 2006; 
Barber et al. 2012; Strauss et al. 2015).  
It is unclear how enteroviral virion-containing extracellular vesicles induce more 
potent viral replication in recipient cells compared to free virions. From the perspective 
of viral evolution, it is reasonable to argue that collective viral genome transfer through 
extracellular vesicles promotes genetic cooperativity, leading to overall enhanced fitness 
of viral replication (Chen et al. 2015). From the standpoint of exosome-mediated cell-to-
cell communication, we hypothesize that in addition to viral genomes, extracellular 
vesicles may transport components of functional viral replication complexes from the 
infected cell to its neighboring cell, leading to a rapid onset of viral replication in the 
recipient cell. Here, we tested our hypothesis by a complementary set of biochemical and 
structural studies on extracellular vesicles shed from poliovirus-infected cells. Poliovirus 
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was chosen because it has been long considered as a prototype for studying enteroviral 
infection.  
Through a series of biochemical analyses, we found that consistent with recent 
work (Chen et al. 2015), virion-containing extracellular vesicles are infectious, known as 
infectious extracellular vesicles (IEVs). IEVs carry functional replication complex 
components including proteins and viral RNAs to initiate a rapid onset of viral replication 
in the recipient cell. Cryo-ET was performed to provide the first reconstructed 3D 
structures of well-hydrated, unstained IEVs. The IEVs, easily distinguishable from 
extracellular vesicles of mock-infected cells, assume unique structural features. The IEV 
distinct structural and biochemical features indicate the involvement of multiple cellular 
pathways, which may contribute to increased infectivity. In addition to IEVs, my work 
shows that CD9 positive exosomes are involved in transporting virions en bloc from cell 
to cell.  
3.2 Results 
3.2.1 Capsid Proteins and Viral Replication Complexes are Present in IEVs 
Poliovirus RNA replication peaks from 3 to 4 hpi (Novak and Kirkegaard 1991).  
From 6 to 8 hpi, there is a sharp increase in extracellular viral titer without a permeability 
of plasma membrane (Chen et al. 2015), indicating that 8 hpi is the peak time for IEVs’ 
release, prior to cell lysis (Chen et al. 2015). To characterize IEVs, it was important to 
first characterize the infection process in our tissue culture system. We harvested mock- 
and poliovirus- infected HeLa cells at various time points post infection. Cytoplasmic 
lysates were normalized using GAPDH protein levels and probed for 3D-containing viral 
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proteins (3CD and 3D both are essential for viral replication) using SDS-PAGE 
immunoblotting. RT-qPCR was performed to detect the level of positive (+) and negative 
(-) sense viral RNAs. qPCR quantitatively measured the expression intensity of (+) and (-
) sense viral RNA by comparing the normalized Cycles to Threshold (Ct) of PCR of all 
the biological replicates between infected and mock groups.  
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Figure 3.1 The cellular level of 3D-containing proteins and viral RNAs. (A) Whole 
cell lysates from poliovirus and mock-infected cells were collected at various post-
infection time points and subjected to SDS-PAGE, followed by immnunoblotting with 
an antibody against 3D-containing proteins. The sample loading was normalized to the 
cell housekeeping protein GAPDH. (B) Total RNA was extracted from the whole cell 
lysate of poliovirus and mock-infected cells. Fold-change increases in viral (+) sense 
viral RNAs from infected cells (IW+) at various post-infection time points (hpi) were 
determined by RT-qPCR. The inset shows the change in early stage infection. (C) The 
level of (-) sense viral RNA of infected cells (IW-) at 8 hpi was examined. All RT-
qPCR data were normalized against whole cell GAPDH (ΔCt =Ct cell viral RNA – Ct 
cell GAPDH), compared to the mock-infected group (Fold change = 2–ΔΔCt = 2-[(Ct– Ct 
GAPDH) infected group – (Ct – Ct GAPDH) mock group]. The data are displayed as mean ± standard 
deviation from at least three independent experiments (*** indicates significance of < 
0.001. n ≥ 3). 	
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As shown in Figure 3.1 (A), the non-structural viral protein 3CD was produced as 
early as 1 hpi, and its levels stayed constant from 3 to 8 hpi. Viral polymerase 3D was 
generated at high levels by 5 hpi. Production of (+) sense PV genomic RNA and (-) sense 
viral replication templates was demonstrated by RT-qPCR using primers shown in 
Methods (Chapter 2.Table 1), using cellular levels of the housekeeping protein GAPDH 
to normalize the results. The combined use of a tag-specific primer and viral RNA 
sequence specific primer is able to: 1) generate full-length viral cDNA products; 2) 
distinguish cDNA transcribed from (+) sense RNA from that of (-) sense RNA. This 
allows accurate quantification of genome and anti-genomic strands (Burrill et al. 2013; 
Plaskon, Adelman, and Myles 2009). RNAs in infected cells are reported in Figure 3.1 
(B), as compared to mock-infected cells, at various time points of infection.  In accord 
with previously reported RNA levels (e.g. Novak and Kirkegaard 1991), the generation 
of (+) sense viral RNA experienced a rapid increase of 270-fold from 3 to 4 hpi. The 
production of both (-) and (+) sense viral RNAs was examined at 8 hpi at the peak (Chen 
et al. 2015). The abundance of (-) RNA in infected cells showed an enormous increase 
relative to mock-infected cells, as did the quantity of  (+) sense viral RNA genomes. 
Extracellular vesicles are known to transport proteins and RNA between cells 
(Valadi et al. 2007). Virus-induced extracellular vesicles secreted from infected cells 
contain mature virions (Robinson et al. 2014; Chen et al. 2015). We therefore 
hypothesized that in addition to virions, proteins and RNA essential for viral replication 
would be present in extracellular vesicles shed by poliovirus-infected cells. 
Phosphatidylserine (PS) binds to annexin-V with a strong affinity (Köhler et al. 1997). 
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Lysates of phosphatidyl serine (PS)-enriched extracellular vesicles were collected and 
purified, using annexin-v-coated beads, from mock- and PV-infected cells (Chen et al. 
2015). To test for essential viral replication proteins, we probed the samples with SDS-
PAGE/Tricine-SDS gels and western blotting, using antibodies against 3D-containing, 
3A-containing, and 2C-containing viral proteins. As shown in Figure 3.2 (A), the 
essential viral replication proteins 2BC, 2C, 3AB, 3A, 3CD, 3D, were present in 
infectious extracellular vesicles (IEVs), but not in extracellular vesicles purified from 
mock-infected cells (MEVs). Next, RNA was extracted from IEVs and MEVs and 
examined by RT-qPCR. As seen in Figure 3.2 (B), a 104-fold increase in (+) sense PV 
RNA was detected in IEVs as compared to MEVs, demonstrating the presence of viral 
genomic RNA in IEVs.  To our surprise, a 500-fold increase in (-) sense PV replication 
was observed in IEVs, demonstrating the presence of viral template RNAs.  
3.2.2 (-) sense Viral RNAs were Protected by IEV’s Membranous Structure 
We hypothesized that the detected (-) sense anti-genomic template RNAs were 
likely protected by intact membranes of IEVs, independent of capsids. To test this 
hypothesis, extracellular vesicles from mock- and poliovirus -infected cells underwent a 
series of membrane-breaking treatments including freeze-thaw and detergent (sodium 
deoxycholate) extraction, followed by RNAse treatment to remove exposed and 
unprotected RNA. As expected (Bienz et al. 1992), because capsids are unaffected by 
freeze-thaw, detergent, or RNases, the majority of (+) RNA was still present in treated 
IEV samples. However, as shown in Figure 3.3, a decrease of 17% in the abundance of 
viral genome was observed, indicating that not all (+) sense viral RNA was protected 
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inside mature virions.  Remarkably, this treatment led to disappearance of all detectable 
(-) sense RNA in broken IEVs. These data indicate that all (-) sense RNA replication 
templates and part of (+) sense RNA genomes are unencapsidated, yet protected from 
harsh environments by membrane structures of IEVs. Taken together, these findings 
demonstrate that PV-induced IEVs carry multiple cargos, including viral replication 
machinery components and RNA, in addition to assembled virions containing genomic 
RNA.  
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Figure 3.2 Viral replication proteins and RNAs in infectious extracellular vesicles. 
(A) Extracellular vesicles, collected through centrifugation at 10 k x g, from 
supernatants of poliovirus and mock-infected HeLa cells (IEV/MEV) at 8 hpi, were 
probed by immunoblotting with antibodies against poliovirus capsid proteins 
(VP0,1,2,3,4), 2C, 3D or 3A, respectively. Samples were subjected to SDS-
PAGE/Tricine-SDS with loading normalized to total protein levels quantified by 
bicinchoninic acid assay (BCA). (B) Extracellular vesicles were resuspended with 1X 
PBS, and (+) and (-) sense viral RNAs (IEVs/MEVs+ and IEVs/MEVs-) were 
determined from the total RNA extraction. The RT-qPCR data were normalized against 
whole cell GAPDH levels (ΔCt =Ct viral RNA in EVs – Ct cell GAPDH), compared to 
the mock-infected group (Fold change = 2 –ΔΔCt = 2-[(Ct gene of interest in EV – Ct cell GAPDH) infected 
group – (Ct gene of interest in EV – Ct cell GAPDH) mock group]. They were displayed as the mean ± 
standard deviation from at least three independent experiments (biological replicates), (n 
≥ 3). 
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Figure 3.3 Viral RNAs in post-treatment infectious extracellular vesicles. 
Collected IEVs underwent: 1) no treatment (IEV/MEV); 2) freeze-thaw treatment 
followed by RNAase incubation (DRIEV/DRMEV) to degrade any unprotected 
RNA, prior to total RNA extraction and determination of (+) sense and (-) sense 
RNAs using RT-qPCR, (n ≥ 3). The table below the graph illustrates three treatment 
conditions the sample went through, + indicating going through and –indicating not 
going through. The RT-qPCR data were normalized against whole cell GAPDH 
levels (ΔCt =Ct viral RNA in EVs – Ct cell GAPDH), compared to the mock-
infected group (Fold change = 2 –ΔΔCt = 2-[(Ct gene of interest in EV – Ct cell GAPDH) infected group – 
(Ct gene of interest in EV – Ct cell GAPDH) mock group]. MEV: mock-infected extracellular vesicles; 
IEV: poliovirus-infected extracellular vesicles.  	
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3.2.3 Intact Extracellular Vesicles are Infectious and Functional 
IEVs shed by poliovirus-infected cells were infectious, consistent with recent 
studies (Robinson et al. 2014; Chen et al. 2015), as shown in Figure 3.4 by plaque assays.  
To test whether the infectivity of IEVs was effected by transport of replication 
components that were previously identified by western blots (Figure 3.2), we infected 
cells with the same number of virions in three different forms: cells were infected with 
individual virions produced by 1) freeze/thaw or 2) freeze/thaw followed by detergent 
and RNase treatment, or 3) with the same sample without disruption of the IEVs. The 
intact IEV sample therefore contained the same number of virions as treated (broken) 
IEVs, and was expected to infect one cell en bloc. As diagrammed in Figure 3.4 (A), one 
intact IEV generated a single plaque when multiple virions infected one cell, whereas 
infection by that number of released individual infectious virions was expected to 
produce one plaque per virion. This is quantified in Figure 3.4 (B) by an increase of 5.7 
fold in plaque-forming units, measured after disruption of the IEVs.   
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Figure 3.4 The infectivity of infectious extracellular vesicles	
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If transported replication components were functional, we expected to see that 
upon infection, IEVs initiated a faster and stronger production of daughter (+) sense viral 
RNA than cells infected with individual virions. To test this hypothesis, we infected cells 
with the same total number of virions, yet in two different forms: freeze/thaw treated 
(FT) IEVs at a multiplicity of infection (MOI) of 1, as determined by plaque assays, or 
intact IEVS that contained multiple virions in each vesicle. As seen in Figure 3.4 (C), 
	
Figure 3.4 The infectivity of infectious extracellular vesicles. (A) A cartoon model 
for experimental procedures used in (B and C). (B) Shed extracellular vesicles from 
infected cells (IEVs) or mock cells (MEVs) were freeze-thawed x3 (FT), followed by 
detergent and RNAse treatment (FTDR) in some experiments. The infectivity of intact 
or treated extracellular vesicles was quantified by standard plaque assay with * P < 
0.05. (C) HeLa cells were incubated with either intact IEVs/MEVs; or IEVs/MEVs 
treated with FT or with FTDR. Infections were performed using an MOI of 1 PFU per 
cell for 30 min at 4 °C, and collected at 1 hpi, 2 hpi, 3 hpi. Total RNA was extracted 
from the whole cell lysates from each experiment at various time points and the level 
of (+) sense RNA viral genome was determined using RT-qPCR. The RT-qPCR data 
were normalized against whole cell GAPDH RNA levels compared to the mock-
infected group, and displayed as the mean ± standard deviation from at least three 
independent experiments, (** P < 0.01. n ≥ 3). 	
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detection of newly-synthesized (+) sense RNA was quantified via RT-qPCR from 1 to 3 
hpi. Our data revealed that, at 3 hpi, intact IEV-mediated infection induced a greater than 
100-fold increase in the generation of daughter viral genomes over cells infected with 
broken FT IEVs. Further, we observed no significant difference in infectivity between FT 
and FT-detergent-RNAse treated (FTDR) IEVs (Figure 3.4), indicating that intact IEVs 
were necessary for enhanced RNA production.  
 
3.2.4 Exosomes from Poliovirus-infected Cells were Infectious 
Virion-containing extracellular vesicles from Coxsackievirus-infected cells carry 
the exosomal protein marker flotillin-1 (Robinson et al. 2014). Interestingly, IEVs from 
poliovirus-infected cells seemed to share more physical similarity with shedding 
microvesicles, as evidenced by a larger averaged size (~200 nm in diameter) (Chen et al. 
2015). To investigate whether exosomes may have a role in poliovirus spread, exosomes 
shed from mock- and poliovirus- infected cells were collected. Free poliovirus virions are 
smaller than exosomes (28 nm vs. 40-100 nm in diameter).  In order to avoid cross-
contamination and ambiguity caused by the presence of free viral particles, collected 
exosomes were further affinity purified using magnetic beads coated with antibodies 
against the surface exosome-specific marker CD9 (Figure 3.5, A). Infectivity of purified 
exosomes shed by poliovirus-infected cells was determined and quantified using plaque 
assays, as performed with IEVs. Similar to experiments above, HeLa cells were infected 
with intact purified exosomes, FT exosomes, or exosomes from mock-infected cells. 
Consistently, exosomes were infectious and exhibited a three-fold increase in infectivity 
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after disruption of the membranous structures by freeze/thaw (Figure 3.5). Thus, 
exosomes may contribute to nonlytic viral transmission utilized by poliovirus.  
 
 
 
	
Figure 3.5 The infectivity of exosomes from poliovirus-infected cells. Exosomes 
from poliovirus and mock-infected cells were collected through a series of 
centrifugation steps and purified using magnetic beads coated with antibodies 
against CD9 (A). (B) The infectivity of isolated CD9 positive exosomes was 
quantified by standard plaque assay. Alternatively, the isolated CD9 positive 
exosomes were freeze-thawed x 3 times, prior to plaque assay. The data were 
displayed as the mean ± standard deviation from at least three independent 
experiments, (n ≥ 3). 	
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3.2.5 Mass Spectrometry Analyses of IEVs and Infectious Exosomes 
We did a proteomic analysis on extracellular vesicles shed by poliovirus and 
mock-infected cells using LC/MS to see what other proteins these vesicles might carry. In 
order to minimize contamination from fetal bovine serum (FBS) that is necessary for cell 
survival while maintaining a vibrant viral replication, infected cells were cultured in 
FBS-supplemented DMEM for 4 hours and then switched to medium without FBS for 
additional 4 hours. Compared to MEVs where only four non-keratin (the main system 
contamination) proteins were identified, 70 proteins were detected in IEVs. As shown in 
Figure 3.6, the top 5 most abundant categories included proteins involved in RNA 
binding (6), cytoskeleton-plasma membrane connection (3), endocytotic/exosomal 
pathway (3), annexin family (7), and the heath shock protein family (4). Annexin proteins 
were the most abundant. CD55 and CD59, involved in host immune system activation, 
were also detected. Interestingly, infectious CD9 positive exosomes were most enriched 
in RNA binding proteins, which account for over 50% of all detected proteins. RNA 
binding proteins present in both IEVs and infectious exosomes include heterogeneous 
nuclear ribonucleoproteins (hnRNP) and ribosomal proteins (RS family). Annexin-2 
protein was the most dominant annexin protein in both IEVs and infectious exosomes. 
CD55 and CD59, present in both vesicle types from infected cells, showed a lower 
abundance rate in exosomes. In contrast, CD9 positive exosomes from mock-infected 
cells had a low level of RNA binding proteins.  
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Figure 3.6 Proteomic analysis of extracellular vesicles. (A) The protein 
abundance in infectious extracellular vesicles (IEVs). (B) The protein abundance 
in mock extracellular vesicles (MEVs). (C) The proteomic profile of CD9 
positive exosomes from infected cells. (D) The proteomic profile of CD9 
positive exosomes from mock-infected cells. The abundance of each category in 
both (A) and (B) was normalized to the GAPDH level in IEVs and infectious 
exosomes, respectively.  	
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3.2.6 Ultrastructural Studies of Multiple Classes of IEVs 
As shown above, the architecture of IEVs accommodates viral capsid proteins, 
RNA, and essential viral replication proteins. To understand this architecture, IEV and 
MEV samples were preserved in a near-native state by rapid plunge freezing, in 
preparation for cryo-electron microscopy, cryo-electron tomography (cryoET) and three-
dimensional (3D) reconstruction.  Examination of 2D low dose images and 3D 
reconstructions computed from tilt series from over 180 vesicles revealed that all IEVs 
were enclosed by a single outer membrane and contained virions. IEVs showed a very 
wide of range of sizes, with diameters ranging from 68 nm to 822 nm. Although 
approximately 90% of IEVs were 100 to 300 nm in diameter, with a median of 171 nm (n 
= 210 vesicles, Figure 3.7), IEVs did not display a strong uniformity in size, nor a strong 
correlation between size and number of included virions. As seen in Figure 3, 83% of 
IEVs carry 1 to 20 virions, with an average of 10 virion particles per vesicle (n = 150 
vesicles, Figure 3.7). No virion-like structures were observed within vesicles from mock-
infected cells (Figure 3.8).  
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Figure 3.7 Three classes of infectious extracellular vesicles 	
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Figure 3.7 Three classes of infectious extracellular vesicles. Panel (A-G) Cryo-
electron micrographs display three major classes of infectious extracellular vesicles 
(IEVs). Panel (A’-G’) Trace models of features in A-G. (A-D) Class I: clusters of 
virions (individual representatives displayed in red in A’-G’) are densely packed and 
occupy the entire space of IEVs. (E-F) Class II: virions are concentrated at one or two 
ends of an IEV. In both class I and II, ramen-noodle-like structures were closely 
associated with virions (traced in purple in A’-G’), and enclosed by the outer 
membrane (brown) of the IEVs. (G) Class III: in addition to virions and threads, inner 
membranous vesicular structures (blue) were observed in IEVs, the interior content of 
which is traced in yellow (G’). The darkest beads with strong defocus rings (e.g. those 
in the lower right corner of panel E) were annexin-V-coated magnetic beads used to 
enrich PS-enriched extracellular vesicles from infected cells. The scale bar of all 
electron micrographs is 100 nm. Statistical analysis of IEVs (n = 177) was used to 
examine the distribution of classes (H), vesicle diameters in nm (I), and the number of 
virions per IEV (J).  	
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Figure 3.8 Extracellular vesicles from mock-infected cells. (A-F) Electron 
micrographs of extracellular vesicles from mock-infected cells (MEVs), collected at 8 
hpi. (A-C) Actin-filaments are clearly seen in some MEVs. (A-D) MEVs with much 
less electron density of their interior contents can be single-membraned. (E) some 
MEVs are double membraned. (F) MEVs can contain an enclosed vesicular structure. 
The scale bar is 100 nm for all images.  	
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Further morphological studies showed that IEVs can be categorized into three 
major classes, based on the arrangement of macromolecular structures within the IEVs. 
As shown in Figure 3.7, virions were either densely packed inside an IEV—class I 
(Figure 3.7 (panel A-D)), or concentrated on one or two ends of an IEV—class II (Figure 
3.7 (panel E-F)). Interestingly, the packing arrangement did not appear to be related to 
individual IEV size. For example, a relatively bigger IEV with a diameter of 200 nm 
could have class I morphology (Figure 3.7 panel D) or class II polar features (Figure 3.7 
panel E-F). IEVs from both class I and II enclosed strong electron density within the 
lumen. Because this prominent electron density displayed tangled thread-like structures, 
we call them “Ramen noodle”-like densities, and have modeled them in purple in Figure 
3.7 panel A’-F’. In addition to virions and sponge densities, class III vesicles had an inner 
vesicular structure. Within the light-colored inner lumen of their inner vesicles, we 
observed central thread-like densities.  
 The outer membranes of IEVs were not smooth, characterized by regions of 
fuzzy electron densities (black arrow, Figure 3.7 panel B and G) and spike-like structures 
(blue arrow, Figure 3.7 panel C and G). In contrast, the major recognizable components 
within mock EVs, which were lacking in most IEVs, were disordered bundles of actin 
filaments (Figure 3.8).  
3.2.7 Characterization of 3D Structures of Extracellular Vesicles 
A more detailed characterization of the structural features of extracellular vesicles 
required an analysis of vesicles in three dimensions (3D). We therefore collected cryo-ET 
data and computed 3D reconstructions of purified IEVs and exosomes shed by 
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poliovirus-infected cells at 8 hpi. Consistent with the 2D cryo-EM images, IEVs fell into 
three classes. Over 90% of IEVs exhibited the class I or class II morphology while only 
10% displayed class III features. IEVs were rarely spherical and showed a single 
membrane enclosing an irregularly shaped structure, with an angular outer contour. 
Virions and thread-like sponge structures, seen in Figure 3.9, were observed within the 
lumen of IEVs. The inner contents of IEVs either occupied the entire lumen in a densely 
packed manner in class I vesicles, (Figure 3.9 panel A), or displayed a polar spatial 
arrangement with density at one or both ends in class II vesicles (Figure 3.9 panel B). The 
majority of class II IEVs contained “empty” lumenal volume that comprised up to 90% of 
the entire volume of the IEV. The outer membrane of IEVs was characterized by punctate 
electron densities that, on closer inspection, appeared to correspond to transmembrane 
proteins (Figure 3.10, black arrow, panel A and B,) and to membrane-associated “head-
stalk” spike-like proteins (Figure 3.10, blue arrow, panel C and D). These outer 
membrane protein features were delineated differently when IEVs were imaged using 
different microscopes and imaging conditions. The FEI TF20 electron microscope 
operated with an accelerating voltage of 160 kV and a CMOS camera was able to depict 
components of IEVs clearly with a strong contrast but with a loss of details (Figure 3.10, 
panel A and C). IEVs observed with an accelerating voltage of 300 kV and a direct 
electron detector, using a Titan Krios electron microscope, preserved the details of lipid 
bilayers at the cost of good contrast (Figure 3.10, panel B and D).  
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Figure 3.9 Ultrastructural studies of infectious extracellular vesicles & exosomes	
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Figure 3.9 Ultrastructural studies of infectious extracellular vesicles & exosomes.  
(Panel A-C) Tomographic slices, 16 nm thick, of 3D reconstructed structures of cryo-
preserved infectious extracellular vesicles (IEVs). (Panel D) Tomographic slices, 16 
nm thick, of exosomes from poliovirus-infected cells. (A’-D’) Cartoon model 
illustration of corresponding tomographic slices on the left. Consistent with 2D cryo-
electron micrographs in Figure 3.2.7, these reconstructed tomographic data each 
display an irregularly-shaped, single membrane vesicle (modeled in brown) that 
bounds multiple virions (modeled as red hexagons in A’-D’), ramen noodle-like 
structures (traced and modeled in purple in A’-D’), and/or an inner vesicular structure 
(modeled in blue). (Panel A’’-D’’) 3D surface rendering of the same vesicles, rotated 
around x-,y-,z- axis for a clear view of the spatial arrangement of IEVs and exosomes 
of each class. The darkest beads with strong defocus ring are annexin-V-coated 
magnetic beads used to enrich PS-enriched IEVs from infected cells. Exosomes were 
collected through a series of centrifugation steps. The scale bar for all images is 50 
nm.  
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Figure 3.10 Membrane-associated proteins in infectious extracellular vesicles.  
(A and B) Cryo-electron tomographic slices depict transmembrane proteins (black 
arrow). A’, B’ are the boxed (red) region of A and B at 2X magnification. (C and 
D) Tomographic slices show head-stalk like proteins (blue arrow). C’, D’ are the 
boxed region (blue) of C, D, shown at 2X magnification. The data in Panel A and 
C were imaged on an FEI TF20 electron microscope at 160 kV with a CMOS 
camera, which displays clearly different components of an IEV with strong 
contrast, yet loses details of double-membraned structures. In contrast, a clear 
double-membraned lipid bilayer structure was captured when the IEVs were 
imaged on a Titan Krios at 300 kV with a direct electron detector (B and D). E and 
F are cartoon models of cryo-electron tomographic data of transmembrane 
proteins and head-stalk like proteins, respectively.  	
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In addition to virions and ramen noodle-like structures, class III IEVs carried 
inner vesicular structures. Figure 3.9 panel C illustrates one single-membrane vesicle 
entrapped in the lumen of an IEV. The average ratio of the radius of the inner vesicle (r) 
over that of its IEV carrier (R) was approximately 0.5 +/- 0.057 (n = 17). Thread-like 
density was clearly visible inside the inner vesicles, as seen in Figure 3.9 panel C, traced 
and modeled in yellow in C’. Distinct from the tightly tangled “Ramen Noodles” like 
structures carried by IEVs and described above, threads here were more loosely tangled 
and more distinctly separated from each other, suggesting that structures inside the larger 
compartment of IEVs or within inner vesicles most likely reflect either two distinct 
macromolecules, or the same macromolecule but in two different structural forms.  
3D structural analysis of exosomes shed by PV-infected cells displayed a more 
uniform size, with an average diameter of 68.5 nm ± 27 nm and an average of 7 ± 3.6 
virions per exosome (n = 10). The predominant morphology of exosomes from infected 
cells corresponded to features seen in class I of IEVs, with a densely packed interior 
volume.  
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Figure 3.11 Unusual structural features of infectious extracellular vesicles. (A-
D) Successive nanometer thick slices through one reconstructed cryo-electron 
tomograms. (A’-D’) Traced models of (A-D) depict the protruding process of an 
inner vesicular structure (blue) as the tomogram slices go from the bottom to top. 
(E-H) Successive nanometer thick slices through another reconstructed tomogram. 
(E’-H’) Traced models of (E-H) show the disappearance and appearance of virions 
and empty capsids among actin filaments (black arrow). Representative virions are 
modeled as solid red hexagons and empty capsids are modeled as unfilled red 
hexagons. The scale bar is 100 nm.  	
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Figure 3.12 Membrane associated pentamers. (A-B) Tomographic slices, 16 nm 
thick, from two cryo-electron tomograms of IEVs that each enclose a pentamer-like 
structure. (A’-B’) Traced models of (A-B), respectively. Virions are identified by 
shape and size in IEVs, and modeled as red hexagons in A’ and B’. A pentamer-like 
structure (modeled in dashed red in B’) is seen in each, with less central electron 
density than virions. The pentamers are associated with and enclosed by a 
membranous structure (modeled in blue). The pentamer appears to be directly 
associated with the membrane through strap-like structures, modeled in red. Scale 
bars are 100 nm.  
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Overall, IEVs’ morphological features fell into a wide spectrum despite three 
major classes. Occasionally, some distinct IEVs were observed. Compared to 
extracellular vesicles from mock-infected cells, it was uncommon to see actin filaments 
inside IEVs. However, Figure 3.11 shows that, in a rare case, virions and empty 
icosahedral virion-like particles that had much less electron density compared to standard 
virions, were scattered between actin filaments within the lumen of IEVs. As shown 
above, over 90% of IEVs carried 10 to 20 virions. However, in one instance, 70 virions 
were seen densely loaded within a large IEV (Figure 3.11). In addition to virions and 
ramen noodle-like structures commonly identified in IEVs, empty icosahedral virion-like 
particles and multiple inner vesicular structures were also identified within some IEVs.  
3.2.8 Membrane-associated Pentamer in IEVs 
When the polyprotein P1 precursor is cleaved into three individual capsid proteins 
VP0, VP1, VP3, these three capsid proteins, rather than scattering in the cytoplasm in a 
free form, remain associated to form a 5S capsid protomer that is the basic building block 
for the well-characterized subviral 14S particle. Empty 75S capsids are comprised of 60 
copies of 5S (Bruneau et al. 1983; Putnak and Phillips 1981). In some IEVs, we observed 
a pentamer-like object enclosed by and attached to a small membranous structure, as if 
the “pentamer” was physically supported by the surrounding single membrane (Figure 
3.12). Together, the pentamer plus membrane was usually slightly bigger than 28 nm in 
diameter. The density of the “pentamer” was different from standard mature virions 
observed above, and distinguishable from packed virions. 
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3.3 Discussion 
3.3.1 IEV-mediated Transfer of Viral Replication Components Contributes to 
Increased Infectivity 
Non-lytic viral transmission utilized by enteroviruses has great implications. 
Here, we demonstrated that in addition to multiple virions, IEVs shed from poliovirus-
infected cells transport functional viral replication components to the recipient cell 
wherein a rapid onset of a new round of viral replication is initiated (Figure 3.13). In 
addition, we showed that CD9 positive exosomes also transport virions from cell to cell. 
Thus, the exosomal pathway appears to be involved in enteroviral non-lytic transmission 
of infection. Although purified exosomes and IEVs from infected cells are distinct in 
their size range, both are infectious, single-membraned vesicles that mediate cell-to-cell 
non-lytic viral transmission. Furthermore, the similarity shared by these two manifests 
itself in the observed increase in infectivity upon freeze-thaw treatments (Figure 3.4, A 
and 3.5, B). Therefore, we discuss purified IEVs and exosomes from infected cells 
together here. 
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Figure 3.13 Model for non-lytic viral transmission	
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Figure 3.13 Model for non-lytic viral transmission.  In addition to mature virions, 
viral replication complex components, including viral proteins, (-) sense viral RNAs 
and sometimes, membranous structures along with immature virions and empty 
capsids, are selectively packed into a double-membraned vesicle in poliovirus infected 
cells. These double-membraned vesicles are enriched in PS and resemble 
autophagosomes. These vesicles fuse with the plasma membrane and release single-
membraned PS-enriched vesicles loaded with clusters of virions and viral replication 
components. This released extracellular vesicle is internalized by the recipient cell 
through a PS-mediated path. Once internalized, the outer membrane of the vesicle is 
disrupted and inner contents are released into the cytoplasm. There are two ways to 
establish viral replication in the recipient cell: 1) mature virions can migrate cross the 
plasma membrane and interact with the CD155 receptor through a canonical 
transmission pathway. Virion-receptor interactions trigger conformational changes in 
capsids, releasing genome RNAs into the cytoplasm to establish a replication 
complex; 2) transported viral proteins, (-) sense viral RNA, and perhaps membranous 
structures, provide essential components, which enables a quicker establishment of 
new mature replication complexes in the recipient cells.  
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Transport of genetic materials and viral proteins through exosomes is a common 
mechanism by which virulence is modulated during viral spread (Meckes and Raab-
Traub 2011). Exosomes, serving as a messenger from infected cells, influence viral 
infection in neighboring cells. The exploitation of exosome has been intensely studied in 
enveloped retroviruses e.g. HIV where the similarity between retroviruses and exosomes 
is striking as to composition, biogenesis and release (reviewed in Gould, Booth, and 
Hildreth 2003). This influence, depending on the type of neighboring/recipient cells, can 
promote the new round of infection or trigger anti-viral host defensive responses in 
recipient cells.  For example, HCV-RNA-containing exosomes released from HCV-
permissive cells activate an immuno-stimulatory response in neighboring HCV-non-
permissive dendritic cells to hinder viral replication in HCV-permissive cells (Dreux et 
al. 2012). Similarly, the lymphotropic Epstein-Barr virus (EBV), an enveloped, double-
stranded DNA virus, has been reported to trigger an inflammatory response in 
noninfected dendritic cells through selective exosomal transfer of 5’-triphosphates-viral 
RNA (Baglio et al. 2016). However, exosomes that transport replication-competent 
subgenomic RNA of HCV are capable of establishing viral replication in HCV-
permissive cells (Longatti et al. 2015). Our data show that poliovirus infection affects 
neighboring poliovirus-permissive cells through extracellular vesicle-mediated transfer of 
clusters of viral genomes and replication components.  
Our observation (not shown) is consistent with the previous report (Chen et al. 
2015) that poliovirus is characterized with a stronger plaque-forming-unit (PFU) capacity 
through IEV-mediated cell-to-cell transmission than cells that are infected by poliovirus 
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released from IEVs, in the form of free virions at the same multiplicity of infection 
(MOI). In this scenario, poliovirus infects cells in two forms: 1) multiple virions are 
transported en bloc in an intact IEV, each IEV counting as one viral infection unit; 2) 
individual virions are freed from breaking IEVs, each productive virion counting as one 
viral infection unit. As a result, cells are infected with more virions in total in the form of 
an intact IEV than when infected with free virions, under the assumption of the same 
MOI. Thus, a stronger infectivity, evidenced by more plaques in plaque assays and the 
detection of increased viral replication (viral protein 3AB production), was observed in 
intact IEVs (Chen et al. 2015). Conversely, at a fixed total number of virions, more 
plaques are generated by free virions released from broken IEVs than intact IEVs (Figure 
3.4).  In addition, high numbers of viral genomes entering a cell may enable viral 
cooperation through genetic recombination, leading to enhanced replicative fitness 
(Altan-Bonnet 2016). Based on the expected increase in fitness, Chen et al. (2015) 
proposed a model in which the increased infectivity is induced by IEV-mediated transfer 
of virions en bloc. However, from the perspective of vesicle transfer, it is reasonable to 
hypothesize that IEVs from infected cells transport RNAs other than viral genomes, as do 
exosomes, into the recipient uninfected cells. Interestingly, we found that in addition to 
the (+) sense viral genome, (-) sense viral replication templates are also present in IEVs. 
Disruption of IEVs’ membrane structures and degradation of unprotected RNAs further 
proved that (-) sense templates (Figure 3.3) are not accidently packaged into capsids, 
because they are absent following this treatment. This result is supported by previous 
work showing that (+) sense genomes (not (-) sense templates) are specifically recruited 
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during viral assembly (Nomato et al., 1977; Novak and Kirkegaard 1991; Jiang et al. 
2014). Rather, our data show that (-) sense viral RNAs, protected by membranous 
structures, were included within IEVs along with viral proteins 3CD, 3D, 2BC, 2C, 3AB, 
3A (Figure 3.2 and 3.3), all of which are essential components of viral replication 
machinery. Importantly, these IEV-transported viral replication components are 
functional, as shown by our data that broken IEVs failed to induce the same replication 
efficiency in recipient cells as did intact IEVs (Figure 3.4, B). Together, our data 
demonstrate that IEV-mediated transfer of viral replication components contributes to 
increased infectivity of poliovirus.  
3.3.2 Three classes of extracellular vesicles from infected cells 
Morphologically, extracellular vesicles from poliovirus-infected cells fall into 
three classes. Virions are either densely packed in extracellular vesicles, termed class I, or 
display a polar arrangement with inner content concentrated at the ends of IEVs, termed 
class II, or they may include an additional inner vesicular structure, termed class III. In 
addition to virions, all three classes harbor tangled ramen noodle-like structures, 
(modeled in purple, Figure 3.7 and 3.9). As discussed above, extracellular vesicles 
transport viral replication components including genetic material and viral proteins, such 
as the poliovirus polymerase 3D. Here, we argue that tangled ramen noodle-like 
structures in IEVs may be transported viral replication components, e.g. viral RNA bound 
to viral and host RNA-binding proteins for protection and initiation of RNA replication. 
In support of this model, it is known that poliovirus polymerase 3D can bind and utilize 
primed RNA templates (Van Dyke and Flanegan 1980). At high concentration, viral 
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polymerase 3D oligomerization enables cooperative binding of poliovirus (+) and (-) 
sense RNAs, and efficient RNA template utilization (Pata, Schultz, and Kirkegaard 
1995). 3AB is another RNA-binding protein. Covalent attachment of 3B (VPg) to all 
newly formed viral RNA is essential for genome replication (Nomoto et al. 1977). In 
vitro research further showed that 3AB interacting with 3D stimulates its polymerase 
activity, even at a low polymerase concentrations (J. Lama et al. 1994), and that most 
viral RNA was bound to large complexes (Pata, Schultz, and Kirkegaard 1995).  
Host proteins also contribute to viral infectivity. (+) sense RNA viruses co-opt 
host RNA-binding proteins (RBPs) to facilitate replication and evade RNA degradation 
in host cells (Pata, Schultz, and Kirkegaard 1995; Z. Li and Nagy 2011). Poliovirus (+) 
sense RNA contains both protein-coding and untranslated regions (UTRs). Similar to 
cellular mRNA, it displays specific RNA structures with secondary and tertiary structural 
elements, and there are dynamic interactions of viral RNA with host RNA-binding 
proteins (RBPs), forming functional ribonucleoprotein (RNP) complexes (Andino, 
Rieckhof, and Baltimore 1990; Z. Li and Nagy 2011). For example, 3CD can interact 
with host heterogeneous nuclear ribonucleoprotein (hnRNP). Impairment of this binding 
inhibits the synthesis of poliovirus (+) sense RNAs (Brunner et al. 2005). In another 
example, polypyrimidine-tract-binding protein, a host RNA binding protein, has been 
found to be an integral component of HCV replication complexes. This interaction 
contributes to efficient viral RNA synthesis, probably through recruiting viral RNA to 
detergent-resistant membrane structures to prevent RNA degradation (Aizaki et al. 2006). 
Our mass spectrometry data consistently showed the presence of eukaryotic translation 
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elongation factor 1A (eEF1A) in IEVs (Figure 3.6). eEF1A is a host RBP that has been 
identified in the replication of positive strand RNA viruses of both plants and animals 
(Mateyak and Kinzy 2010). eEF1A binds an aa-tRNA-like element in the 3’-NTR of the 
turnip yellow mosaic virus genome and represses (-) strand RNA synthesis to coordinate 
the completion of translation (Matsuda, Yoshinari, and Dreher 2004). In the West Nile 
virus replication, disruption of eEF1A binding to the 3’NTR of the viral genome leads to 
a decrease in (-) strand synthesis and a corresponding decrease in progeny productions 
(Murray et al. 2004). eEF1A also interact with RNA-dependent RNA polymerase in 
tobacco mosaic virus and tombusvirus replication complexes (Z. Li et al. 2009). All of 
these studies have implicated that binding of eEF1A to the virus genome is important for 
viral replication. Additionally, as one of the most abundant protein synthesis factor, 
eEF1A has been ascribed many functions outside of its canonical role in polypeptide 
chain elongation. Early studies showed a potential role for eEF1A in protein quality 
control and co-translational degradation (Gonen et al. 1994). eEF1A could interact with a 
native polypeptide chain and a misfolded protein, but not a folded protein (Hotokezaka et 
al. 2002). Here, the mass spectrometry data demonstrated that IEVs carry heat shock 
proteins HSP 70 and 90, which are classical chaperones that promote de-novo folding of 
nascent proteins, refolding of misfolded proteins, and targeting misfolded proteins to the 
proteasome (reviewed in Shiber and Ravid 2014). It is plausible to argue that transporting 
eEF1A through IEVs regulates both viral RNA replication and translation to promote a 
rapid onset of efficient viral infection. We suspect that transported viral RNAs are not 
naked in extracellular vesicles from infected cells, but rather are bound to viral and host 
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RNA-binding proteins for viral RNA protection and replication, with a tangled ramen 
noodle-like structural feature.  
This tangled ramen noodle-like structure is observed in all classes of IEVs and 
purified exosomes from poliovirus infected cells, over 90% of which fall into class I and 
class II (Figure 3.7). This observation suggests a possibility that class III, in which an 
inner vesicular structure is present, may be an anomalous class of IEVs that includes 
encapsidation of active-state viral replication. That is, perhaps the inner vesicular 
structures have been accidently packed within class III IEVs. Autophagy is involved in 
the release of IEVs from poliovirus-infected cells (Jackson et al. 2005; Bird et al. 2014; 
Chen et al. 2015). siRNA-mediated depletion of autophagic protein LC 3 leads to a 
decrease in intracellular virus production, and notably, a much severe decrease in the 
release of extracellular virions (Jackson et al. 2005) and IEVs (Bird et al. 2014). This 
may sound counter-intuitive since the autophagic degradation pathway is a powerful 
mechanism to protect against cytosolic pathogens in host cells. However, the 
involvement of autophagy in this non-lytic viral transmission is reminiscent of several 
positive-stranded RNA viruses that subvert the cellular autophagic pathway to enhance 
infection. These include Coxsackievirus (Wong et al. 2008), poliovirus (Jackson et al. 
2005; Richards and Jackson 2012), dengue virus (Panyasrivanit et al. 2009), and hepatitis 
C virus (Taguwa et al. 2011), which all utilize the autophagic pathway for viral 
replication and maturation. Furthermore, Altan-Bonnet’s group demonstrated the 
colocalization of membrane-associated (lipidated) LC 3 and mature virions in poliovirus-
infected cells using an antibody specially against the cleaved VP2 protein that is only 
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present in mature virion (Chen et al. 2015). Inhibition of LC 3 expression decreases both 
intracellular and extracellular levels of virions, indicating the importance of acidification 
for late stage poliovirus replication (Jackson et al. 2005; Richards and Jackson 2012).  
It is possible that the non-lytic viral transmission pathway hijacks multiple 
cellular pathways for biogenesis and release of extracellular vesicles. The exosomal 
pathway is involved in non-lytic release of infectious particles, as purified CD9 positive 
exosomes are infectious and exhibit changes in infectivity. The treatment of freeze-thaw, 
detergent, and RNases causes the same consequences in exosomes as in IEVs (Figure 
3.5). Other studies have also suggested that autophagic and endocytic pathways may 
converge as autphagosomes that are proven to be a fusion partner for endosomes as well 
as multivesicular bodies (MVBs) (Liou et al. 1997). Previously, our laboratory observed 
a MVB-like vesicle that is loaded with virions and multiple inner vesicular structures, in 
the subcellular fractionation of viral replication membranes (not shown). We think it is 
plausible that the biogenesis of IEVs and or infectious exosomes starts with LC 3-
mediated autophagosome engulfment, followed by fusion to MVB or the plasma 
membrane to release single-membraned vesicles. Alternatively, the innermost membrane 
of a double-membraned autophagosome-like vesicle disperses as engulfed virions mature 
in an acid environment. The outermost membrane of such vesicle directly fuses with the 
plasma membrane to release their contents into the extracellular space. This pathway is 
also called autophagosome-mediated exit without lysis (AWOL) (Jackson et al. 2005, 
2005; A. L. Richards and Jackson 2012b).  Interactions between autophagic and 
endocytic pathways explain why endocytic-MVB-exosomal pathway is involved. 
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Another pathway that may participate in the non-lytic transmission pathway is shedding 
vesicles. On rare occasions, we observed actins along with mature and empty capsids in 
released IEVs (Figure 3.11). Actin cytoskeleton proteins are commonly found in the EVs 
, which  directly bud from the surface of plasma membrane and are released into the 
extracellular space (Cauwenberghs et al. 2006; Turturici et al. 2014). Actin filaments are 
commonly observed in our mock-infected extracellular vesicles (Figure 3.2.8). 
Occasional observation seen in Figure 3.11, suggested that dispersed mature virions and 
empty capsids in the cytoplasm may directly be packed into actin-containing shedding 
vesicles through the common plasma membrane budding and fission process. Lastly, 
under some circumstances, clusters of dispersed mature virions and empty capsids may 
also directly interact with the PS-enriched region of the plasma membrane and bud from 
the region, a point we will discuss more later (Figure 3.11). 
3.3.3 Morphological features of extracellular vesicles from infected cells 
One of the most conspicuous features of extracellular vesicles from poliovirus-
infected cells is their heterogeneity in size. IEVs and purified exosomes span a wide 
spectrum of sizes, from 43 nm to 822 nm in diameter. In vitro, studies on spontaneous 
vesiculation have revealed that membrane stiffness and bilayer thickness are two 
important factors that mediate vesicle size distribution (Huang et al. 2017). In 
physiological conditions (37 °C), changes in membrane composition are the primary 
driving force in changes in the thickness and bending stiffness of membranes (Huang et 
al. 2017). Increases in membrane stiffness and thickness promote the formation of larger 
vesicles (Huang et al. 2017). Distinguishable from phosphatidylcholine (PC) and 
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phosphatidylethanolamine (PE), the neutral charge of the serine portion of PS results in 
an anionic lipid. Its negative charge has made PS the preferred target of interacting with 
polycations and proteins with cationic clusters (Lemmon 2008). Furthermore, the 
presence of PS increases membrane flexibility and lowers the bending/deformation 
energy barrier, leading to positive spontaneous vesiculation (Huang et al. 2017)  
Conversely, a negative curvature contributes to an even higher deformation energy 
barrier with much reduced bending and vesiculation of membrane. For example, PC 
exhibits either zero curvature spontaneity (C10-14, forming flat lamellar structures) or the 
negative curvature when its acyl chain length is longer (C16-18) (Szule, Fuller, and Rand 
2002). Either scenario would promote formation of larger vesicles. 
Is it possible that poliovirus orchestrates membrane composition, which leads to 
heterogeneous sizes of extracellular vesicles? During infection, poliovirus induces a shift 
in lipid composition, abundance, and location in infected cells. For example, PC is a 
phospholipid normally found on the inner leaflet content of plasma membrane, and the 
luminal leaflet of the ER membrane (Leventis and Grinstein 2010). During poliovirus 
infection, the elevated biosynthesis of PC changes from short (C14) to long (C16/18) 
acyl-chain in infected cells (Nchoutmboube et al. 2013). PC is considered the major 
constitutive component of membranous replication complexes (Vance, Trip, and Paddon 
1980). Other anionic phospholipids, phosphatidylinositol-4-phosphate (PI4P) and PS 
(Hsu et al. 2010; Chen et al. 2015), along with cholesterol (Ilnytska et al. 2013) are 
enriched in membranous replication complexes in infected cells.  
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Studies on Ebola virus, an enveloped virus, showed that its major viral structural 
protein VP40 selectively interacts with anionic PS and induces membrane vesiculation 
including budding and scission (Soni and Stahelin 2014). Previous research (Chen et al. 
2015) showed that PS-rich membrane domains were found across the viral replication 
membranous structures as early as 4 hpi. Early research reported that purified poliovirus 
virions can be encapsulated in a PS-enriched large unilamellar vesicle and these vesicles 
with their associated virus are biologically infectious and active when exposed to cells 
(Wilson, Papahadjopoulos, and Taber 1977). Poliovirus viral proteins including the 
structural protein VP1 and nonstructural membrane-associated proteins are positively 
charged (Karlin and Brendel 1988). We suggest that the positively charged transported 
contents in IEVs selectively interact with the PS-enriched domain of membrane 
structures to promote vesiculation. Meanwhile, we speculate that poliovirus induces 
changes in the concentration and presence of other lipids such as PC and cholesterol in 
the membrane, to counteract excess formation of smaller vesicles induced by PS. 
Altogether, the delicate balance of viral-induced lipid composition may contribute to the 
heterogeneity in size of extracellular vesicles released by poliovirus-infected cells.  
The concept that lipid composition contributes to size and character of vesicles 
would also explain the observation of the polar arrangement of inner contents in class II 
IEVs (Figure 3.9, Panel B): transported virions and replication components that are 
positively-charged (Karlin and Brendel 1988; Koch and Koch 1995, p56) may selectively 
interact with the PS-enriched region of vesicular structure, which leads to positive 
curvature regions of IEVs (Figure 3.7, F and Figure 3.9, Panel B). On that note, PS 
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enriched regions in such vesicles may protrude and extend from the IEVs, as traced in 
blue (Figure 3.11, A-D). Additionally, it is not impossible that clusters of dispersed 
mature virions and capsids may directly interact with PS in the inner leaflet of the plasma 
membrane, which leads to vesicle budding out of infected cells. Protein-lipid interaction 
is often a driving force of membrane remodeling. By inserting the amphipathic helix, 
membrane and membrane-associated proteins create uneven stresses to generate positive 
or negative curvature. The EM data showed the presence of membrane-associated and 
transmembrane proteins on the outermost membrane of IEVs (Figure 3.10), which may 
contribute to IEVs’ morphological features. 
 
3.3.4 Transported Viral Replication Components in IEVs 
The replication complex is a virus-induced membrane-associated entity, which 
may be considered as an organelle, in poliovirus-infected cells (Belov et al. 2012; 
Jackson 2014).  Electron microscopy studies have shown that during viral infection, the 
complex gradually transitions from connected, single-membraned vesicular clusters into 
separate, double-membraned vesicles with clearly defined membrane boundaries (Belov 
et al. 2012; Rossignol et al. 2015). Tracking the locations of active replication sites in 
infected cells is important for understanding the generation of such an organelle. To date, 
double-stranded viral RNA (dsRNA) has been considered as a reliable and specific 
marker of replication sites. Compared to viral replication complex proteins that have 
multiple functions, double-stranded RNAs occur at two locations:  at production sites of 
(+) sense RNA, which are transcribed to (-) sense RNA templates to initiate replication; 
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and in reverse at sites of (-) sense RNA, which serves as a template to generate progeny 
(+) sense genomes (Hsu et al. 2010; A. L. Richards et al. 2014). Antibody localization 
studies and in situ RNA hybridization can be difficult to perform, presumably due to 
RNAses that are present in the environment of essentially all preparations, including 
experiments performed to break open IEVs. Here, we found that breaking open IEVs and 
digesting all un-encapsidated RNAs led to an evident decrease in (+) sense RNAs, with 
the majority remaining intact (Figure 3.3). The decrease indicates that some (+) sense 
RNAs are not packed inside capsids, and we propose that some un-encapsidated (+) sense 
RNA is likely to be present with (-) sense RNA inside IEVs in the form of dsRNAs, 
suggesting sites of active viral replication.  
3D reconstructions of class III IEVs display an inner vesicular structure wherein 
some thread-like linear structures are present (Figure 3.9). Despite the low resolution, the 
linear continuity of this feature is reminiscent of a single dsRNA observed previously by 
Rossignol (Figure 3.16. thesis of Evan Rossignol, 2015). Inner luminal vesicles of IEVs 
have head-stalk protein-like structures attached on the inner leaflet of the bi-layer, 
pointing inwards (Figure 3.14). Despite the limited number of particles, my preliminary 
work on sub-volume averaging analysis displays a reconstructed average model of the 
head-stalk shaped proteins. Although more samples and further analysis are required to 
determine the identity of such head-stalk shaped protein, it has morphological similarities 
to the F1-ATPase of mitochondrial membranes (Abrahams et al. 1994). We hypothesize 
that this membrane-associated protein from IEVs could be viral protein 2C. 
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Figure 3.14 Membrane-associated head-stalk like protein on the inner vesicular 
structure of an infectious extracellular vesicle. (A) A reconstructed tomographic 
slice with a thickness of 8 nm shows a class III IEV collected and purified from 
poliovirus-infected cells. The blue-colored box corresponds to the enlarged image 
shown on the right, which was magnified 3.5 X. The red arrow points to a virion 
attached on the inner vesicular membrane while black arrows point to two 
representative head-stalk like proteins with the stalk attached to the membrane. Head-
stalk like proteins were picked from the same single tomogram shown in (A) for sub-
volume averaging. (B) Resulting sub-volume average of 8 picked head-stalk protein 
tomographic volumes. (C) The unfiltered iso-surface model of (B). The cartoon model 
between (B) and (C) delineates the head and stalk features of such protein. (D) 
Predicted structure of enterovirus 71 2CATPase using the HMMSTR/Rosetta server 
(Figure 1 C. Xia et al. 2015). The N-terminal domain (NTD), the middle nucleotide-
binding domain (NBD) and the C-terminal domain (CTD) are indicated. Scale bars are 
50 nm (A), 10 nm (B and C).  
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Poliovirus 2C protein is a relatively conserved protein among members of 
Picornaviridae family (similarity is restricted to their folded tertiary structures with little 
sequence similarity) (Pfister and Wimmer 1999). The protein is characterized by three 
domains: the N terminus (NTD), the central nucleotide-binding domain (NBD), and the C 
terminus (CTD) (Paul et al. 1994; Teterina et al. 1997). 3D computational modeling 
analysis of Enterovirus71 2C protein (Xia et al. 2015) indicates that the NTD forms the 
stalk of the protein, extending to associate 2C with the membrane. The CTD and NBD 
comprise the head of the protein (Figure 3.14). Functionally, 2C binds to the (+) sense 
viral RNA genome to initiate (-) sense RNA synthesis (Rodríguez and Carrasco 1995b). 
Moreover, an interaction between 2C and capsid protein VP3 is essential for specifically 
sorting (+) sense viral genomes into capsids during viral packaging (Liu et al. 2010). Our 
data showed the proximity of such head-stalk like membrane associated proteins with 
thread-like structures in the inner luminal vesicle, suggesting the possible presence of an 
active, on-going replication site.  
We observed two membrane-associated proteins on IEVs: the head-stalk like 
proteins on the external surface of the outer membrane of IEVs (Figure 3.10 blue arrow) 
and head-stalk like proteins located at the inner leaflet of internal vesicles (Figure 3.14). 
Are they the same? Enveloped viruses such as HCV and HIV, usually have glycoprotein 
spikes on their membranous envelopes (McCune et al. 1988; Earl et al. 1990). Among 
poliovirus viral proteins, an early study (Datta and Dasgupta 1994) showed that 3AB and 
3A can be glycosylated in vitro. Immuno-electron microscopy of our sample probed for 
3AB showed the presence of 3A-containing proteins (3AB) on the IEV membrane 
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(Figure 4.5). However, so far, we know little about whether the spikes observed on the 
surface of outer membranes of IEVs are 3A-containing proteins or glycosylated 3A-
containing proteins.  
3.3.5 Implications for poliovirus morphogenesis  
One interesting observation from our 3D cryo-electron tomographic analysis is 
the appearance of empty capsids and membrane associated pentamer-like density in 
IEVs, in addition to mature packed virions that exhibit a strong internal density (Figure 
3.11 and 3.12).  
Briefly, cleaved VP0, VP1, and VP3 from capsid protein P1, quickly assemble 
into the capsid building block, a 5S protomer unit (extracted particles that sediment at 5S) 
(Palmenberg 1982). Five 5S protomers then assemble into a 14S pentamer (Ansardi et al. 
1992). Twelve 14S pentamers then assemble into a 75S, empty icosahedral capsid (no 
viral RNA) that contains 60 copies each of VP0, VP1, VP3 (Ansardi et al. 1994). When 
an icosahedral capsid harbors a viral RNA genome, the viral particle is called a 150S 
provirion, which is the precursor of the mature virion (Guttman and Baltimore 1977). 
Lastly, a mature infectious virion is generated when VP0 is cleaved into VP2 and VP4 
(Hogle et al. 1985).  
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Figure 3.15 Model for poliovirus morphogenesis	
		
102 
 
 
	
Figure 3.15 Model for poliovirus morphogenesis. (A) Virion assembly process: P1 
is cleaved into VP0, VP1, VP3, three of which assemble into a protomer 5S; Five 
protomers subsequently form a 14S pentamer; Some pentamers can further generate 
75 S empty capsids; Pentamers are further selectively associated with (+) sense viral 
genome just released from active replication sites, through 2C-VP3 mediated protein-
protein interactions on the surface of a membranous replication complex. (B) Virion 
assembly process is rotated 90 degrees around the X-axis and 90 degrees around the 
Z-axis. In total, 12 pentamers assemble to enclose the viral RNA genome and form a 
provirion 150S. Maturation ensues to generate a mature infectious virion with the 
cleavage of VP0 to VP2 and VP4. (C) A 16 nm-thick tomographic slice (300 kV, 
Titan Krios microscope) shows a membrane-associated pentamer like structure in a 
purified IEV. The segmentation is colored and traced in the bottom. The surrounding 
membrane is traced in blue with the pentamer-like structure traced in red line in the 
center. The pentamer-like structure is attached to the membrane through unknown 
electron density, colored in red line. A representative virion is modeled as a red 
hexagon. The scale bar is 100 nm.  
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How an RNA genome gets packed into a capsid is controversial. Increasing 
evidence supports a model where 14S pentamers are restricted to the viral RNA during 
assembly, to form a provirion (Nugent and Kirkegaard 1995; Liu et al. 2010). Studies 
have indicated that viral replication is prerequisite of, and concomitant with viral 
encapsidation (Molla et al. 1991; Nugent et al. 1999). Biochemical analyses are in accord 
with electron micrographs that display the colocalization of capsid precursors (5S, 
14S,75S and 150S) with isolated replication complex (Pfister and Wimmer 1999).  The 
current proposed model (Figure 3.15) (Nugent et al. 1999; Liu et al. 2010; Jiang et al. 
2014) is that progeny RNA is  synthesized and released from the replication complexes. 
Briefly, synthesized RNA is associated with 14S pentamers through a direct interaction 
between the VP3 of the pentamer, and viral protein 2C on the surface of a membranous 
replication complex. Here, our biochemical and cryo-electron microscopic structural data 
showed the presence of functional replication components and capsid proteins in IEVs 
(western blots), together with a membrane-associated pentamer-like structure in an IEV 
(Figure 3.12). These observations are consistent with a previous report that 14S is closely 
associated with poliovirus replication complexes (Pfister, Egger, and Bienz 1995). 
Together, our data, along with previous studies, further support the proposed model that 
encapsidation of poliovirus RNA starts at replication complexes and is initiated by 14S 
pentamers (Pfister, Egger, and Bienz 1995; Nugent et al. 1999; Liu et al. 2010; Jiang et 
al. 2014).  
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4. Studies of Membrane-remodeling of Viral Protein 3AB 
4.1 Introduction 
Poliovirus-induced membrane remodeling is one of the most conspicuous features 
during infection. The remodeling starts with clustered single-membraned vesicles that 
transition to double-membraned vesicles late in infection (Belov et al. 2012; Rossignol et 
al. 2015). RNA replication complexes assemble on or in the vesicular structures (Bienz et 
al. 1987; Hsu et al. 2010; Rossignol et al. 2015). Morphologically, these double 
membraned vesicles resemble cellular autophagosomes, as both vesicular structures have 
double lipid bilayers that enclose cytoplasmic organelles and are associated with lipidated 
LC 3 and late endosomal LAMP-1 (Suhy et al. 2000; Jackson et al. 2005). From the 
perspective of function, poliovirus subverts the autophagic pathway for virion maturation 
(Richards and Jackson 2012a), in accord with the observation of multiple virions packed 
inside double membraned autophagosome-like vesicles (Dales et al. 1965; Belov et al. 
2012). Of note, recent studies on a non-lytic viral transmission pathway utilized by non-
enveloped viruses demonstrate the involvement of autophagy, as evidenced by hindered 
release of virion-containing infectious extracellular vesicles when the level of LC 3 is 
hindered (Jackson et al. 2005; Bird et al. 2014). Conversely, stimulating autophagy 
enhances poliovirus release (Jackson et al. 2005; Bird et al. 2014; Chen et al. 2015). 
Those double-membraned autophagosome-like vesicles are thought to be the precedent of 
IEVs (Taylor and Jackson 2009; Richards and Jackson 2012; Chen et al. 2015). In 
infected cells, double-membraned vesicles containing viral-like particles have both 
phosphatidylinositol-4-phosphate (PI4P) and phosphatidylserine (PS). Enrichment of 
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these phospholipids is observed in viral replication complexes and IEVs, respectively 
(Hsu et al. 2010; Chen et al. 2015).  
Viral proteins 2BC, 2C, 3AB, 3A each possesses an intrinsic capacity for 
membrane binding and remodeling (Cho et al. 1994; N. L. Teterina et al. 1997; Suhy, 
Giddings, and Kirkegaard 2000; Wang et al. 2013). Among them, the combined 
expression of 2BC and 3A in transfected cells induces double-membraned vesicular 
structures similar to those observed during poliovirus infection (Suhy, Giddings, and 
Kirkegaard 2000). While expression of 2BC alone is sufficient to induce the formation of 
large, single-membraned vesicles with few lumenal contents (Cho et al. 1994), HeLa 
cells transfected with 3AB display double-membraned vesicles with a similar topology to 
autophagosomes (Wang et al. 2013). In a cell-free system, the viral protein 3AB, which is 
a 109 amino-acid amphipathic protein with a hydrophobic domain (Strauss et al. 2003), is 
capable of invaginating single-membraned liposomes into horseshoe like lipid structures, 
and into double-membraned liposomes (Wang et al. 2013). Interestingly, co-localization 
of 3AB, viral capsids, and PS was observed in double-membraned autophagosome-like 
vesicles within infected cells (Chen et al. 2015).  
The protein 3AB is multifunctional. For example, its interaction with polymerase 
3D, stimulates the RNA polymerase activity. Thus, 3AB is considered to be a classical 
marker to identify the efficiency of viral protein expression and to locate viral replication 
complexes (A. L. Richards et al. 2014; Chen et al. 2015). The marker feature of 3AB is 
similar to that of double-stranded RNA (dsRNA) during viral infection. It has been 
proposed that viral replication occurs in parallel with encapsidation (Liu et al. 2010). 
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However, little is known about the mechanisms by which viral and/or host proteins 
orchestrate membrane rearrangements to form IEVs in infected cells. It is unclear 
whether double-membraned autophagosome-like vesicles that contain virions derive from 
double-membraned viral replication membranous structures.  
While cell-based experiments can directly look at factors responsible for IEV 
formation in infected cells, they cannot identify the most fundamental proteins 
coordinating the complicated poliovirus membranous invagination. Here, we use a 
modified cell-free system to dig deeper into the membrane-remodeling capacity of 3AB 
to shed light on the mechanism of IEV formation in infected cells.  
 
4.2 Results 
4.2.1 3AB expression and purification 
Based on a previously reported protocol (Wang et al. 2013), poliovirus protein 
3AB was expressed in an IPTG-induced, BL21(DE)pLYs E. coli expression system, 
grown in M9 minimal media, under the control of a T7 promoter. Because 3AB is soluble 
in high-salt (500 mM NaCl) and non-ionic detergent (1% NP-40, or IGEPAL CA-630), 
an anion exchange column was used to bind contaminants, which allows the 3AB-
containing fraction to flow through. The second chromatography step consisted of a 
cation exchange column CM-sepharose, where 3AB was eluted at 200 mM NaCl. The 
eluted fractions were analyzed by Tricine-SDS gel. As shown in Figure 4.1, 3AB-
containing fractions display a strong and clear band at 12 kDa in both steps of 
chromatography. 
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Contamination from bacterial proteins significantly decreased after the cation exchange 
column, with >92% purity, compared to 43% prior to the cationic exchange column. The 
	
Figure 4.1 Expression and purification of 3AB. Viral protein 3AB was expressed 
using a bacterial E. Coli system and purified through a two-step chromatography. The 
results were checked through Tricine-SDS gel. (A) Lanes A1-A3 show the eluates 
(lane A1-A3) of the anion exchange chromatography, which contained the expressed 
protein 3AB, 12 kDa, highlighted in the red square box. (B) After the first (anion) 
exchange chromatography, combined samples containing 3AB went through the 
second cationic exchange column and lanes C1-C3 represent its flow-through that had 
purified 3AB, highlighted in the red square box. For both (A) and (B), lanes +IPTG 
and –IPTG represent the cultivated samples of post-and pre- IPTG induction, 
respectively. M stands for molecular markers.  	
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gel shift in Figure 4.1 (A and B) was probably due to 3AB’s intrinsic membrane-bound 
property. Gel shifting is common for membrane and membrane associated proteins. As 
3AB was purified, the change in detergent ratio in loaded solutions may result in altered 
3AB-detergent binding, which led to a slower migration rate on the gel due to less 
charges from protein-bounded SDS (Rath et al. 2009). 
4.2.2 Reconstitution	of	3AB	into	PI4P-containing	liposomes	
Previously, in order to explore the membrane-remodeling capacity of 3AB, Wang 
et al (2013) determined the optimum lipid composition of liposomes (PC: PE: PS) = 
3:2:1) that can incorporate 3AB to promote protein-induced membrane invagination. 
Because PI4P is an essential lipid component of membranous replication complexes (Hsu 
et al. 2010), we further optimized the previous system by incorporating PI4P. The chosen 
PI4P-containing lipid composition and ratio (PC: PE: PS: PI4P = 10:3:1:1) is similar to 
the Golgi membrane (J. E. Vance 2015). This is consistent with a current theory that 
poliovirus preferentially interacts with Golgi-resident proteins and invaginates Golgi-
membranes for initiation of poliovirus replication (Richards et al. 2014; Jackson 2014). 
As shown in Figure 4.2 (C) this updated protocol yields a majority of single-membraned 
(72%), round PI4P-containing liposomes with a mean diameter of 220 ± 54 nm.  
Various membrane remodeling processes occurred when purified 3AB was added 
into PI4P-containing liposomes. Purified 3AB was solubilized in the IGEPAL CA-630 
detergent, diluted below the critical micellular concentration (CMC) to protect the 
integrity of the liposomes (Wang et al. 2013). In contrast to the round, regularly-shaped, 
unilamellar vesicles of non-protein incorporated liposomes (Figure 4.2, C; Figure 4.3, A), 
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tubular protrusions extended from 3AB-reconstituted liposomes, similar to petal-like 
structures (Figure 4.2, E; Figure 4.3, B). More commonly, irregularly-shaped 
multilamellar and double-membraned vesicles were formed (Figure 4.2, D), which was 
consistent with the previous report that 3AB inherently invaginates single-membraned 
structures (Wang et al. 2013). We also observed 3AB-induced clusters of single-
membraned vesicles (Figure 4.2.2, Figure 4.3). This feature is reminiscent of poliovirus-
induced rosette-like structures extracted from cells as replication complexes of the 30% 
sucrose subcellular fraction (Figure 4.3) (Bienz et al. 1990). The formation of rosette 
structures is reversible upon changing the temperature and salt/ionic concentrations, 
which suggests that rosette formation depends on protein-protein or protein-lipid 
interactions (Bienz et al. 1990).   
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Figure 4.2 Electron micrographs of negatively-stained 3AB-reconstituted, PI4P-
containing liposomes. (A) Subcellular fractions that have RNA replication activity 
show vesicular structures characterized with a rosette-like arrangement from (Bienz et 
al. 1990). Black arrow points at probed protein 2C. V indicates vesicles, RC stands for 
replication complex (Bienz et al. 1990). (B) A dissociated single vesicle from rosette-
like structures displays a stalk-like tubular structure and petal of the rosette (Egger et 
al. 1996). (C) PI4P-containing liposomes. (D-F) Representative EM images of 3AB-
reconstituted, PI4P-containing liposomes with various morphological features. The 
liposomes cluster (D, F) and petal-tube structure (E) mimic features observed in (A) 
and (B), respectively. Scale bars of all images are 100 nm.  	
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Figure 4.3 Reconstitution of 3AB into PI4P-containing liposomes. 3AB-
incoporated liposomes were collected through ultracentrifugation and examined 
under cryo-electron microscopy. PI4P was incorporated to generate PI4P-containing, 
single-membraned liposomes that were prepared the same as in Figure 4.2.2 (D-F). 
(A) A selected representative cryo-electron micrograph of PI4P-containing 
liposomes. (B-D) Representative cryo-electron micrographs of 3AB-reconstituted, 
PI4P-containing liposomes. Scale bar of all images are 90 nm.  
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4.2.3 3AB-induced membrane remodeling encloses large protein particles. 
Poliovirus-induced membrane remodeling starts with clustered and connected 
single-membranous structures and then extends to double-membraned vesicular 
structures. Double-membraned autophagosome-like vesicles wherein virions are 
entrapped are thought to be the precedent of infectious extracellular vesicles (IEVs) 
(Chen et al. 2015). We hypothesized that 3AB contributes to IEV formation through 
entrapping virions into the lumen of double-membraned vesicles as it induces 
invagination of single-membraned structures. A previous report (Wang et al. 2013) shows 
an intermediate horseshoe-like structure with an opening induced by 3AB, suggesting 
	
Figure 4.4 Fluorescent spectrometry of 3AB-induced membrane remodeling.	
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that double-membraned vesicles “leak” contents to stay connected with cytoplasm.  
I performed a fluorescence spectrometry experiment to test if 3AB traps big 
molecules to form enclosed vesicles that can hold contents inside. We incubated purified 
3AB, PI4P-containing liposomes, and Rhodamine Red-X fluorescently labeled secondary 
antibodies together for various periods of time, followed by washes and a determination 
of fluorescent signals in the pellets and supernatants using fluorescent spectroscopy 
(Figure 4.4). If 3AB can invaginate single-membraned vesicles to entrap Rhodamine 
Figure 4.4 Fluorescent spectrometry of 3AB-induced membrane remodeling. (A) 
PI4P-containing liposomes (labeled as L) and 3AB were directly incubated with 
Rhodamine Red-X fluorescent secondary antibodies (labeled as F) for various periods 
of time (group L + 3AB + F). Alternatively, a 2-hour incubation of Rhodamine Red 
antibodies came after a pre-incubation of PI4P-containing liposomes and 3AB for 
various periods of time (group L + 3AB…+F). After incubation, the samples were 
spin down and washed once, followed by detection of fluorescent signals of pelleted 
proteoliposome samples and supernatant. (B) The relative fluorescent intensity of 
proteoliposomes normalized to the total fluorescent signals was used to compare the 
efficiency of entrapment (proteoliposomes + supernatant). L + F stands for PI4P-
containg liposomes (L) incubated with fluorescent antibodies (F) for various periods 
of time. L + F + D stands for PI4P-containg liposomes (L) incubated with fluorescent 
antibodies (F) and detergent IGEPAL CA-630 (D) for various periods of time.  		
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Red-X inside the newly formed double-membraned vesicles, fluorescent signal should be 
measureable in liposome-containing pellets after washes. Un-entrapped free Rhodamine 
Red-X should be left in the supernatant. At 37 °C, in the absence of 3AB, liposome + 
fluorescent antibody (L + F) and liposome + fluorescent antibody  + IGEPAL CA-630 
detergent (L + F + D) showed little fluorescent signal compared to the 3AB-incorporated 
group (liposome + fluorescent antibodies + 3AB (L + F + 3AB)). A fluorescent signal 
was detectable as early as 45-minute incubation and continued increasing to reach the 
maximum signal saturation point at 5 hours post addition. There was no significant 
difference in fluorescent signals between 5 hours and 7 hours post incubation. The 
saturated signal at 5 hours post addition was 1.5 fold and 2.1 fold higher than the 150 
minutes and 45 minutes post incubation, respectively. Alternatively, experiments were 
performed using a 2-hour of fluorescent antibody incubation that came after pre-
incubation of liposomes and 3AB for various periods of time (Liposome + 
3AB…+fluorescent antibodies). The fluorescent signal detected after a 45 minute 
Rhodamine Red-X-incubation fell into the control background when the liposome-3AB 
pre-incubation was prolonged to 2.5 hours, which suggests that the 3AB induced 
membrane invagination normally lasts 2 to three hours (Figure 4.4). Taken together, these 
data show that 3AB is intrinsically able to trigger particle entrapment into vesicular 
lumen through invaginating single-membraned vesicles to form double-membraned 
vesicular structures.  
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4.2.4 Localization of 3AB on IEVs by immuno-electron microscopy  
To further characterize the role of 3AB in IEVs, we immunolabeled 3AB on 
annexin-V purified IEVs from infected cells at 8 hpi, and viewed the location by 
negative-stain immuno-electron microscopy. Polyclonal antibodies raised against a 
synthesized peptide from a 3A-containing protein sequence in rabbit serum (Biomatik) 
were used as the primary probe, followed by an interaction with gold-conjugated anti-
rabbit IgG secondary antibodies. This antibody has been used widely in studying 
poliovirus 3A-containing proteins (3AB and 3A) in immunolabeling experiments (Hsu et 
al. 2010; A. L. Richards et al. 2014; Chen et al. 2015).  
 
Non-specific labeling tends to accumulate around congregated annexin-V 
magnetic beads. For example, compared to mock-infected extracellular vesicles wherein 
a lot of background labeling on magnetic beads was seen (Figure 4.5, A and F), immuno-
gold labeling of 3AB was consistent and obvious, localized to the membrane of IEVs 
(Figure 4.5, B-D) in IEVs. The labeling was quantified as the number of golds divided by 
the surface area of vesicles (nm2). IEVs and MEVs were incubated with 0.05% IGEPAL 
CA-630 detergent in PBS after fixation to increase the permeability of primary antibody. 
As shown in the insets of (B and C) at 1.5 X higher magnification, 78% of 3AB labeling 
localized to the outer cytoplasmic-facing vesicular wall of IEVs, while some 3AB 
labeling was spotted in the inner lumen of IEVs (Figure 4.5, D). Figure 4.5 (F) is the 
quantative analysis of 3AB labeling on both MEVs and IEVs. Gold-conjugated secondary 
labeling without the primary antibody incubation, could be seen on the magnetic beads 
		
116 
but very few on the vesicular structures (not shown). While 3AB labeling was observed 
on the membranous or vesicular structures on the mock-infected cells occasionally (15% 
											 	
Figure 4.5 Immuno-electron microscopy of 3AB on IEVs	
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= the ratio of number of labeling on the membranous or vesicular structures/number of all 
labeling), over 72% labeling of IEV samples was on the vesicular/membranous 
structures, showing a five fold higher specific labeling counts/surface areas.  
4.3 Discussion 
4.3.1 Purified 3AB alone is capable of inducing membrane remodeling of PI4P-
containing vesicles 
Figure 4.5 Immuno-electron microscopy of 3AB on IEVs. (A) Purified extracellular 
samples from mock-infected cells through annexin-V column showed a lot of non-
specific labeling to annexin-V magnetic beads. There were very few PS-positive 
vesicles in the mock-infected extracellular vesicles (MEV). Unbound annexin-V 
magnetic beads tend to aggregate, leading to non-specific labeling of 3AB, shown in 
the red box region. An inset is shown at a higher magnification. (B-D) are negative-
staining electron micrographs of extracellular vesicles from poliovirus-infected cells 
through the annexin-V column. Insets of (B-D) are the red box region of (B-D), shown 
at a higher magnification. Gold-labeling was highlighted by the blue circle. (E) 
Quantitative analysis of 3AB immunolabeling on IEVs and MEVs. The number of 
gold labeling on vesicular structures is given as the number of labeling per nm2 of 
vesicles. (F) A electron micrograph of negatively stained annexin-V microbeads 
alone. The scale bar of 100 nm is for all images.  		
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Here, we showed that purified 3AB is capable of inducing membrane remodeling 
of PI4P-containing single-membraned liposomes with similar lipid composition to the 
Golgi Apparatus. 3AB-induced membrane invagination includes petal-stick tubular 
structures (Figure 4.2.2 (B), 4.3 (E)), double-membraned/multilamellar liposomes (Figure 
4.3 (D), 4.2 (C)), and aggregated rosette-like liposome clusters (Figure 4.2, D; 4.3, C and 
F).  
Early studies (Bienz et al. 1992; Egger et al. 1996) on isolated subcellular 
fractions of poliovirus-infected cellular contents using sucrose gradient centrifugation, 
demonstrated that the 30% sucrose fraction, which contains replicative intermediate (RI) 
and progeny (+) sense viral RNA genomes, exhibits a tightly compacted, rosette-like 
shell of virus-induced vesicles by electron microscopy of negatively stained samples 
(Figure 4.3, A). These vesicular structures can reversibly dissociate into individual 
tubulated vesicles (Figure 4.3, B), which are capable of the initiation and elongation of 
(+) sense RNA, comparable to the assembled rosette clusters. The petal of individual 
dissociated vesicles appears to be double-membraned or multilamellar, attached to a long 
protruding stalk-like tail capped with many small granular structures. Further 
immunoprecipitation experiments showed that capsid proteins, 2C-containing, 3D-
containing and 3A-containing proteins are associated with the isolated rosette-like 
vesicular clusters. Previous work (Cho et al. 1994) showed that 2C, but not 2B, induces 
highly dilated rough ER when expressed alone in cells. These dilated structures appear to 
be either elongated tubular or spiral shaped (Cho et al. 1994). Our laboratory’s study has 
reported the formation of double-membraned vesicles induced by 3AB alone, through 
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negatively curved membranes, both in vitro and in cells (Wang et al. 2013). In addition to 
the presence of double-membraned vesicles, electron microscopy analysis in this work 
revealed 3AB-induced positively-curved, deformed tubular structures protruding from 
vesicles, which (Wang et al. 2013). We consider that this difference is caused by different 
lipid compositions and peripheral membrane-associated protein insertion. Compared to 
the lipid ratios of PC: PE: PS = 3:2:1, which resembles the composition of the 
mammalian ER, additional corporation of PI4P and adjustment of lipid composition to 
PC: PE: PS: PI4P = 10:3:1:1, produce synthesized liposomes closer in composition to the 
Golgi Apparatus (Vance 2015). The current model for novel viral replication complex 
formation includes lipids that originate from both the ER and Golgi Apparatus through 
COPII and COP I vesicular tracking, respectively (Rust et al. 2001; Richards et al. 2014). 
Recruited by poliovirus 3A and 3CD, the Golgi COP I complex Arf1/GBF-1, brings PI4P 
kinase to viral replication membranes for the production of PI4P (Hsu et al. 2010; A. L. 
Richards et al. 2014). PI4P colocalizes with the dsRNA signal throughout viral infection, 
which is critical for efficient viral replication (Hsu et al. 2010). PI4P is a negatively 
charged phospholipid that, in combination with PS, electrostatically defines the 
negatively charged surface landscape of membranous structures (Bigay and Antonny 
2012). It has been reported that PI4P and PS rich membrane recruits additional proteins, 
e.g. 3AB (Hsu et al. 2010; Chen et al. 2015) during infection. Previous studies reported a 
model in which partial membrane insertion of 3AB (D. M. Strauss, Glustrom, and Wuttke 
2003; Wang et al. 2013) only changes the lipid density of the outer leaflet of the bilayer, 
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which leads to a local positive curvature with the membrane protruding outward 
(McMahon and Gallop 2005). 
We showed here that 3AB alone is sufficient to induce tubulated vesicular 
structures. However, immuno-electron microscopy data suggest the involvement of 2C-
containing proteins, as evidenced by labeling of 2C-containing proteins around the 
granular cap of individual tubulated vesicles from infected cells (Egger et al. 1996). Co-
expression of 2C and 3A in cells leads to swollen ER (Cho et al. 1994). It has been 
argued that the replication intermediate (RI) is adsorbed to the surface of the protein-
covered vesicular membranous structures. The tubulated stalk-like structure allows the 
production of full-length genomic RNA from RI that would have to be kept in an 
untangled configuration (Egger et al. 1996). It is plausible to consider that 2C-containing 
proteins generate single-membraned vesicles and together with the insertion of 3AB, lead 
to membrane aggregation, invagination and tubulation.  
4.3.2 Implications for formation of infectious extracellular vesicles 
Little is known about the biogenesis of virion-containing vesicles in infected cells 
prior to their release. Capsid-containing autophagosome-like vesicles are thought to be 
the precursor of IEVs, prior to their release (Jackson et al. 2005; Bird et al. 2014; Chen et 
al. 2015). Several experimental results support this theory: 1) both membranous 
replication complexes and autophagosomes contain phospholipids PI4P and PS (Martens, 
Nakamura, and Yoshimori 2016; Chen et al. 2015); 2) the autophagic pathway protein 
lipidated LC 3 and the endosomal marker LAMP-1, colocalize with mature capsids in 
infected cells (Chen et al. 2015); and 3) inhibiting autophagy impedes the release of 
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virion-containing vesicles in the extracellular space (Jackson et al. 2005; Bird et al. 
2014). Briefly, autophagy starts with the generation of novel membrane crescents called 
phagophores (Mizushima 2007). The phagosphore expands and sequesters cytoplasmic 
contents, leading to formation of a double-membraned vesicular autophagosome (Tanida 
2011). Autophagosomes, then fuse with endosomes to form amphisomes, with increased 
pH in their lumen. Finally, amphisomes fuse with lysosomes, becoming single-
membraned autolysosomes (Eskelinen 2005). Lipidated LC 3 (PE-LC 3) has been shown 
to promote elongation of phagophores and sealing of autophagosomes (Kabeya et al. 
2000; Kabeya et al. 2004). Phagophore expansion requires membrane tethering and 
fusion. LC 3 is able to induce full membrane fusion when anchored only to one 
membrane leaflet via PE (Weidberg et al. 2011). This asymmetric insertion of the N-
terminus of LC 3 promotes positive curvature and tension in the outer leaflet, leading to 
hemifusion and eventually fusion (Weidberg et al. 2011). In accordance, the 
autophagosome biogenesis is a lipid-modulated process: it is essential to have the local 
generation and transfer of intrinsic-curvature-modifying lipids (e.g. PI3P) from cellular 
organelles such as ER to phagophores (Dall’Armi, Devereaux, and Di Paolo 2013). 
Evidence of a relationship between autophagy and virally induced extracellular vesicles 
has been accumulating. For example, up-regulating autophagy increases non-lytic 
poliovirus transmission (Jackson et al. 2005; Bird et al. 2014). lipidated LC 3 has been 
detected on the virion-containing extracellular vesicles released by Coxsackievirus-
infected cells (Robinson et al. 2014).  
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Earlier research showed that expression of viral protein 2BC alone is sufficient to 
recruit LC 3 to membranes, which leads to its subsequent PE lipidation (Taylor and 
Kirkegaard 2007). However, co-expression of 2BC and 3A proteins is required for 
generation of double-membraned vesicles in cells (Taylor and Kirkegaard 2007; Suhy, 
Giddings, and Kirkegaard 2000). 3AB, not 3A, possess intrinsic RNA-binding activity 
that is required for both (+) and (-) sense RNA production and 3D polymerase 
stimulation (Lama, Sanz, and Rodrguez 1995). The cleavage of 3AB into 3A by protease 
3CDpro is a membrane-associated process, dependent of PI4P accumulation in viral 
replication complex (Fujita et al. 2007; Melia et al. 2017). Interestingly, a recent study 
reported that the presence of PI4P and 3AB/3A is essential for the formation of 
membranous viral replication organelles, especially double-membraned vesicles in the 
late stage of infection (Melia et al. 2017). Here, I showed that 3AB is capable of inducing 
double-membraned PI4P-containing vesicles in the cell-free system. Addition of 3AB to 
liposomes enabled engulfing and sequestering of large protein particles (120 kDa) into 
vesicles via membrane invagination (Figure 4.4). These data showing entrapment of 
proteins from solution suggest that 3AB may contribute to sequestering virions in 
autophagosome-like double membraned vesicles in infected cells. Consistent with the in 
vitro data is our detection of 3A-containing proteins on purified IEVs from poliovirus-
infected cells by immuno-electron microscopy (Figure 4.5). Notably, 3A-containing 
protein participates in the non-lytic release of poliovirus through interaction with 
microtubules (Taylor et al. 2009). Disruption of microtubules or mutation in 3A-
containing proteins leads to much earlier and enhanced non-lytic viral transmission 
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(Taylor et al. 2009). What is the role of 3AB in the autophagy-mediated non-lytic viral 
transmission in infected cell?  
4.3.3 Model for biogenesis of IEVs in poliovirus-infected cells 
Although more research is needed, we propose a revised model for biogenesis of 
IEVs in poliovirus-infected cells. Nonstructural membrane-associated proteins 2BC, 2C, 
3AB, and 3A contribute to establishment of PI4P and PS-enriched single-membraned 
connected replication complexes (pre-published data from our laboratory, not shown). 
Some region of this single-membraned complexes harbor active replication sites where 
biogenesis of (+) and (-) sense RNAs, as well as virion assembly, are ongoing. In 
contrast, some region pinch off to form a PS-enriched reservoir decorated with multiple 
viral proteins e.g. 2BC and 3A-containing proteins as well as intrinsic curvature-
modifying lipids. Meanwhile, LC 3 and or lipidated LC 3 are specifically recruited to the 
reservoir. Lipidated LC 3 (and 3AB) initiates the process of autophagosome formation, 
sequestering in its lumen virions and viral replication complex components including 
dsRNAs, viral proteins, and membranous structures where virions are assembled. These 
autophagosome-like vesicles fuse with endosomes to 1) decrease their luminal pH, 
creating an acid environment for maturation of entrapped virions, 2) to form multiple 
vesicular bodies (MVB). These autophagosome-like vesicles and fused MVB contain 3A-
containing proteins that anchor them through microtubules to prevent premature release. 
Around 7-8 hpi, such autophagosomes and MVB fuse with the plasma membrane and 
release their contents into the extracellular space (Figure 4.6).  
 
		
124 
 
 
 
 
							 	
Figure 4.6 Model for biogenesis of virion-containing extracellular vesicles	
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Figure 4.6 Model for biogenesis of virion-containing extracellular vesicles. 
Poliovirus induces membrane remodeling to form PI4P-enriched, PS-containing 
membranous structures as early as 2-3 hpi. In the early stage, large connected 
vesicular structures are dominant, characterized by viral replication sites where active 
replication and assemblies occur. These viral replication sites transition to double 
membraned, more separated vesicles. In contrast, part of the large vesicular structure 
purposefully recruits PS lipids and LC-3 to generate PS-enriched autophagic 
membrane reservoir. From this reservoir, PS-enriched membranous fragments that 
contain LC-3 pinch off, elongate, and engulf immature assembled virions, and or viral 
replication complex components including viral proteins and membrane-bound active 
replication sites. This leads to the formation of virion-containing autophagosome-like 
vesicles. Around 5-7 hpi, immature virions become mature capsids within these 
autophagosome-like vesicles. Between 7-8 hpi, these autophagosome-like vesicles 
migrate to the plasma membrane to release their inner contents. Around 12 hpi, the 
infected cell membrane breaks to release mature virions that have been released into 
the cytoplasm. 	
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5. Final Discussion 
Non-lytic viral transmission in non-enveloped (+) sense RNA viruses has 
attracted more attention lately. Early EM images (Dales et al. 1965) of poliovirus-
infected cells showed a vesicle that contains viral capsid proteins, exiting from the 
plasma membrane prior to cell lysis. Recent studies on HAV (Feng et al. 2013), 
Coxsackievirus (Robinson et al. 2014), Rhinovirus (Chen et al. 2015), and poliovirus 
(Jackson et al. 2005; Bird et al. 2014; Chen et al. 2015) have provided direct evidence 
that demonstrates non-enveloped viruses can be enclosed by membranes and transported 
through vesicles. However, it is unclear what components these virion-containing 
vesicles carry, what are their characteristics, and how the infected cell generates such 
vesicles.  
We show here, for the first time, that virion-containing extracellular vesicles from 
poliovirus-infected cells carry viral replication components including viral proteins and (-
) sense viral RNAs, to initiate a faster viral replication cycle in recipient cells. These 
virus-containing vesicles show distinct morphological features with a wide size range 
from exosomes to shedding vesicles. Together with high pressure freezing/freeze 
substitution electron microscopy from our laboratory previous studies (data not shown 
here), our mass spectrometric analysis of IEVs and exosomes demonstrated that various 
cellular proteins are transported along with virions, which indicates an involvement of 
multiple cellular pathways in the biogenesis of such vesicles.  
Compared to free virion-initiated replication, transporting “extra” luggage of 
proteins and lipid structures induces a much rapid onset of viral infection (Figure 3.4). 
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The carried-on luggage might facilitate and expedite the establishment of membranous 
replication complexes in recipient cells. The detection of virus RNA dependent RNA-
polymerase, un-encapsidated (-) and (+) sense viral RNA, while not directly proving 
RNA synthesis in the vesicle, would support this possibility (Figure 3.2 and 3.3). In free-
virion induced infection, enteroviral replication is preceded by translation for generation 
of essential replication proteins (Baltimore and Franklin 1963). The buildup of viral 
proteins shifts translation to transcription, which is regulated by viral protease 3CD 
(Andino, Rieckhof, and Baltimore 1990). Directly detected on IEVs and infectious 
exosomes, transported 3CD might expedite this transition either by quickly binding to 
released (+) sense genome from capsids or un-encapsidated RNAs (Figure 3.3). 
Meanwhile, membrane associated proteins 2BC, 2C, 3AB, 3A and sometimes, inner 
vesicular structures, might facilitate a quick formation of mature viral replication 
complexes through membrane remodeling in the recipient cell. We recognize that we 
cannot provide an affirmative answer that observed “Ramen noodles” like structures in 
IEVs and infectious exosomes (Figure 3.6 and 3.7) are proteins and protein-bounded 
RNAs. However, the density and features of the “Ramen noodles” structures are in 
agreement with protein and RNA substances observed under cryo-EM. RNA-binding 
proteins interact with RNAs to prevent RNA degradation in cells and to facilitate 
translation or transcription in cells and viruses (Pata, Schultz, and Kirkegaard 1995; 
Burrill et al. 2013). Therefore, it is conceivable that RNA-binding viral and cellular 
proteins interact with un-encapsidated viral RNAs in a form of tangled noodles.  
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Using pre-existing viral replication components also contributes to the idea that 
viruses achieve the long-term fitness through optimizing adaptation. While RNA viruses 
benefit from misincorporation of nucleosides during replication for adaptation (Domingo 
2000; Biebricher and Eigen 2005), deleterious fitness effects could happen as detrimental 
mutations in RNA polymerase or in any essential viral replication components could 
prevent replication. Here, poliovirus packs functionally proven RNA polymerase 3D and 
viral proteins through vesicles to neighboring cells. This may provide an alternative 
avenue for evolutionary optimization: 1) transported viral proteins preserve an active 
replication; 2) the virus may still take advantage of mutation due to the intrinsic lack of 
proofreading function in 3D. This might be why virions always are packed with “Ramen 
noodles” like structures in these vesicles, even only one virion inside. In addition, 
poliovirus could benefit from viral recombination due to the clusters of virion transport 
through vesicles (Kirkegaard and Baltimore 1986).  
Autophagosome-like double membraned vesicles have been proposed to be the 
origin of IEVs (Jackson et al. 2005; Taylor and Jackson 2009; A. L. Richards and 
Jackson 2012a). In this model (Jackson 2014), LC-3 mediated autophagosomes are the 
site for virion maturation and late-stage viral replication. Thus, double-membraned 
autophagosomes migrate to the plasma membrane and release their inner contents such as 
clusters of virions. We demonstrated in this study that exosomes are also involved in 
transporting virions in a non-lytic luggage-carried vesicular manner (Figure 3.5 and 3.8). 
Other data from our laboratory (not shown here) have shown that virions are seen loaded 
in a MVB from subcellular fractionation of poliovirus-infected cells at 4 hpi. In 
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conjunction, the presence of MVB that contains virion-like particles inside, were 
observed in proximity to single and double-membraned vesicles where viral replication 
takes place in infected cells at 5 hpi. We conclude that it is unlikely that autophagy is the 
only cellular pathway that is exploited by viruses to generate virion-containing 
extracellular vesicles. Our mass spectrometric analysis of IEVs supports this possibility 
that IEVs contain proteins involved in the MVB-exosomal pathway and ER-Golgi 
intermediate membrane transporting process (Figure 3.6). Thus, we propose a revised 
model: poliovirus utilizes multiple cellular vesicle transport pathways to generate virion-
containing extracellular vesicles. In Figure 4.6 we suggest one possibility that 1) LC 3 
mediate membrane remodeling of replication membranes or ER to engulf virions along 
with essential viral and cellular proteins to form double-membraned vesicles; 2) some 
double membraned vesicles cross-talk with the MVB-endosomal pathway through fusion; 
3) the MVB that carry autophagosomal marker becomes an alternative site for virion 
maturation and release its inner contents when fusing with the plasma membrane.   
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